Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	vesicle cargo loading	CTAGE9 CTAGE6 SEC31B MIA2 CTAGE8 CTAGE15 CTAGE4	5.68e-09	36	147	7	GO:0035459
GeneOntologyBiologicalProcess	endoplasmic reticulum to Golgi vesicle-mediated transport	CTAGE9 GBF1 CTAGE6 SEC31B MIA2 CTAGE8 SEC16A TRAPPC10 CTAGE15 CTAGE4	2.14e-07	159	147	10	GO:0006888
GeneOntologyBiologicalProcess	regulation of termination of RNA polymerase II transcription	SETX WNK1 SCAF4	1.41e-06	4	147	3	GO:1904594
GeneOntologyBiologicalProcess	Golgi vesicle transport	CTAGE9 GBF1 STXBP5L CTAGE6 SEC31B MIA2 CTAGE8 SEC16A TRAPPC10 CTAGE15 MACF1 CTAGE4	5.90e-06	339	147	12	GO:0048193
GeneOntologyBiologicalProcess	regulation of termination of DNA-templated transcription	SETX WNK1 SCAF4	6.98e-06	6	147	3	GO:0031554
GeneOntologyBiologicalProcess	positive regulation of glucokinase activity	RGPD4 RANBP2 RGPD3	2.89e-05	9	147	3	GO:0033133
GeneOntologyBiologicalProcess	positive regulation of hexokinase activity	RGPD4 RANBP2 RGPD3	4.10e-05	10	147	3	GO:1903301
GeneOntologyBiologicalProcess	presynaptic active zone organization	PCLO PCDH17 RIMS2	4.10e-05	10	147	3	GO:1990709
GeneOntologyBiologicalProcess	positive regulation of termination of DNA-templated transcription	SETX WNK1	5.05e-05	2	147	2	GO:0060566
GeneOntologyBiologicalProcess	positive regulation of termination of RNA polymerase II transcription	SETX WNK1	5.05e-05	2	147	2	GO:1904595
GeneOntologyBiologicalProcess	secretion	CTAGE9 RHBDF1 TSPOAP1 STXBP5L SYT17 PCLO DVL1 IRS1 CTAGE6 WNK1 CHRM3 NCOR2 MIA2 PAX8 PRKAA1 CTAGE8 CTAGE15 CACNA1H CTAGE4 RIMS2 MUC2 OC90	5.42e-05	1221	147	22	GO:0046903
GeneOntologyBiologicalProcess	intracellular transport	RGPD4 CTAGE9 RANBP2 GBF1 ENTR1 BAG3 ANKLE1 CTAGE6 MLXIP SEC31B WNK1 MICALL1 MIA2 ALMS1 MAP1S ATXN1 RGPD3 CTAGE8 SEC16A TRAPPC10 CTAGE15 CTAGE4 RIMS2 PCNT MGRN1	5.46e-05	1496	147	25	GO:0046907
GeneOntologyBiologicalProcess	negative regulation of collateral sprouting	BCL11A DCC ULK1	7.44e-05	12	147	3	GO:0048671
GeneOntologyBiologicalProcess	regulation of glucokinase activity	RGPD4 RANBP2 RGPD3	9.63e-05	13	147	3	GO:0033131
GeneOntologyBiologicalProcess	regulation of hexokinase activity	RGPD4 RANBP2 RGPD3	1.22e-04	14	147	3	GO:1903299
GeneOntologyBiologicalProcess	collateral sprouting	DVL1 BCL11A DCC ULK1	1.36e-04	37	147	4	GO:0048668
GeneOntologyBiologicalProcess	termination of RNA polymerase II transcription, poly(A)-coupled	SETX SCAF4	1.51e-04	3	147	2	GO:0030846
GeneOntologyBiologicalProcess	regulation of termination of RNA polymerase II transcription, poly(A)-coupled	SETX SCAF4	1.51e-04	3	147	2	GO:2000804
GeneOntologyBiologicalProcess	protein secretion	CTAGE9 RHBDF1 STXBP5L PCLO IRS1 CTAGE6 CHRM3 MIA2 CTAGE8 CTAGE15 CTAGE4 RIMS2	1.73e-04	480	147	12	GO:0009306
GeneOntologyBiologicalProcess	establishment of protein localization to extracellular region	CTAGE9 RHBDF1 STXBP5L PCLO IRS1 CTAGE6 CHRM3 MIA2 CTAGE8 CTAGE15 CTAGE4 RIMS2	1.83e-04	483	147	12	GO:0035592
GeneOntologyBiologicalProcess	termination of RNA polymerase II transcription	SETX WNK1 SCAF4	1.86e-04	16	147	3	GO:0006369
GeneOntologyBiologicalProcess	synaptic signaling	SLC12A6 AMPH TSPOAP1 STXBP5L PCLO ZMYND8 DVL1 LAMA2 DCC GRM5 WNK1 CHRM3 LRIT3 PCDH17 DLGAP3 RNF167 ATXN1 RIMS2	2.06e-04	976	147	18	GO:0099536
GeneOntologyBiologicalProcess	protein localization to extracellular region	CTAGE9 RHBDF1 STXBP5L PCLO IRS1 CTAGE6 CHRM3 MIA2 CTAGE8 CTAGE15 CTAGE4 RIMS2	2.09e-04	490	147	12	GO:0071692
GeneOntologyBiologicalProcess	regulation of developmental growth	SGIP1 SYT17 BCL2 BCL11A DCC ALMS1 CTDP1 MACF1 ULK1 RIMS2 RAI1	2.22e-04	421	147	11	GO:0048638
GeneOntologyBiologicalProcess	regulation of cellular component size	SLC12A6 PCLO ESAM BCL11A DCC WNK1 CRACD ABCB8 MACF1 ELN ULK1	2.46e-04	426	147	11	GO:0032535
GeneOntologyBiologicalProcess	negative regulation of developmental growth	BCL11A DCC ALMS1 CTDP1 ULK1 RAI1	2.89e-04	126	147	6	GO:0048640
GeneOntologyBiologicalProcess	anterograde trans-synaptic signaling	SLC12A6 AMPH TSPOAP1 STXBP5L PCLO ZMYND8 DVL1 LAMA2 DCC GRM5 WNK1 CHRM3 PCDH17 DLGAP3 RNF167 ATXN1 RIMS2	3.51e-04	931	147	17	GO:0098916
GeneOntologyBiologicalProcess	chemical synaptic transmission	SLC12A6 AMPH TSPOAP1 STXBP5L PCLO ZMYND8 DVL1 LAMA2 DCC GRM5 WNK1 CHRM3 PCDH17 DLGAP3 RNF167 ATXN1 RIMS2	3.51e-04	931	147	17	GO:0007268
GeneOntologyBiologicalProcess	nuclear export	RGPD4 RANBP2 BAG3 ANKLE1 WNK1 ATXN1 RGPD3	3.69e-04	185	147	7	GO:0051168
GeneOntologyBiologicalProcess	NLS-bearing protein import into nucleus	RGPD4 RANBP2 RGPD3	3.70e-04	20	147	3	GO:0006607
GeneOntologyBiologicalProcess	trans-synaptic signaling	SLC12A6 AMPH TSPOAP1 STXBP5L PCLO ZMYND8 DVL1 LAMA2 DCC GRM5 WNK1 CHRM3 PCDH17 DLGAP3 RNF167 ATXN1 RIMS2	3.87e-04	939	147	17	GO:0099537
GeneOntologyBiologicalProcess	triglyceride homeostasis	CTAGE9 MIA2 CTAGE8 MED13	4.42e-04	50	147	4	GO:0070328
GeneOntologyBiologicalProcess	acylglycerol homeostasis	CTAGE9 MIA2 CTAGE8 MED13	4.77e-04	51	147	4	GO:0055090
GeneOntologyBiologicalProcess	presynaptic active zone assembly	PCLO PCDH17	4.97e-04	5	147	2	GO:1904071
GeneOntologyBiologicalProcess	regulation of protein-containing complex disassembly	SETX WNK1 SCAF4 CRACD MAP1S CAMSAP1	5.88e-04	144	147	6	GO:0043244
GeneOntologyCellularComponent	endoplasmic reticulum exit site	CTAGE9 CTAGE6 SEC31B MIA2 CTAGE8 SEC16A CTAGE15 CTAGE4	5.02e-10	42	148	8	GO:0070971
GeneOntologyCellularComponent	Golgi lumen	HSPG2 MUC16 MUC5B MUC12 MUC1 MUC2 MUC4 MUC20	1.08e-06	109	148	8	GO:0005796
GeneOntologyCellularComponent	nuclear inclusion body	RGPD4 RANBP2 ATXN1 RGPD3	1.07e-05	20	148	4	GO:0042405
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RGPD4 RANBP2 RGPD3	1.90e-05	8	148	3	GO:1990723
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RGPD4 RANBP2 RGPD3	4.02e-05	10	148	3	GO:0044614
GeneOntologyCellularComponent	annulate lamellae	RGPD4 RANBP2 RGPD3	1.20e-04	14	148	3	GO:0005642
GeneOntologyCellularComponent	nuclear pore nuclear basket	RGPD4 RANBP2 RGPD3	2.62e-04	18	148	3	GO:0044615
GeneOntologyCellularComponent	SUMO ligase complex	RGPD4 RANBP2 RGPD3	4.21e-04	21	148	3	GO:0106068
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	RGPD4 CTAGE9 RANBP2 RHBDF1 ESYT1 ATP10B BCL2 CTAGE6 ERN2 SEC31B CHRM3 LRIT3 MIA2 RGPD3 CTAGE8 SEC16A CTAGE15 ITPRIP ULK1 CTAGE4 GPSM1	4.40e-04	1327	148	21	GO:0042175
GeneOntologyCellularComponent	inclusion body	RGPD4 RANBP2 BAG3 ATXN1 RGPD3	4.51e-04	90	148	5	GO:0016234
GeneOntologyCellularComponent	neuromuscular junction	STXBP5L PCLO LAMA2 LAMA5 DLGAP3	1.21e-03	112	148	5	GO:0031594
GeneOntologyCellularComponent	cytoskeleton of presynaptic active zone	PCLO RIMS2	1.36e-03	8	148	2	GO:0048788
GeneOntologyCellularComponent	ribbon synapse	AMPH PCLO RIMS2	1.48e-03	32	148	3	GO:0097470
HumanPheno	Decreased nerve conduction velocity	SLC12A6 SETX LAMA2 WNK1 SACS ATXN1 CTDP1 RAI1	1.65e-05	112	53	8	HP:0000762
HumanPheno	Abnormal nerve conduction velocity	SLC12A6 SETX LAMA2 WNK1 SACS ATXN1 CTDP1 RAI1	2.58e-05	119	53	8	HP:0040129
Domain	FAM47	FAM47A FAM47C FAM47B	1.71e-06	4	142	3	PF14642
Domain	FAM47	FAM47A FAM47C FAM47B	1.71e-06	4	142	3	IPR032743
Domain	SEA	HSPG2 MUC16 MUC12 MUC1	2.11e-05	22	142	4	PF01390
Domain	LAMININ_IVA	HSPG2 LAMA2 LAMA5	2.34e-05	8	142	3	PS51115
Domain	Laminin_B	HSPG2 LAMA2 LAMA5	2.34e-05	8	142	3	PF00052
Domain	LamB	HSPG2 LAMA2 LAMA5	2.34e-05	8	142	3	SM00281
Domain	Laminin_IV	HSPG2 LAMA2 LAMA5	2.34e-05	8	142	3	IPR000034
Domain	SEA	HSPG2 MUC16 MUC12 MUC1	2.53e-05	23	142	4	PS50024
Domain	SEA_dom	HSPG2 MUC16 MUC12 MUC1	2.53e-05	23	142	4	IPR000082
Domain	DVL-1	DVL1P1 DVL1	5.74e-05	2	142	2	IPR008340
Domain	Ran_BP1	RGPD4 RANBP2 RGPD3	9.00e-05	12	142	3	PF00638
Domain	RANBD1	RGPD4 RANBP2 RGPD3	9.00e-05	12	142	3	PS50196
Domain	RanBD	RGPD4 RANBP2 RGPD3	1.16e-04	13	142	3	SM00160
Domain	Ran_bind_dom	RGPD4 RANBP2 RGPD3	1.16e-04	13	142	3	IPR000156
Domain	SEA	HSPG2 MUC16 MUC1	1.47e-04	14	142	3	SM00200
Domain	Interferon_reg_fac2-bd1_2_Znf	IRF2BP2 IRF2BPL	1.71e-04	3	142	2	IPR022750
Domain	IRF-2BP1_2	IRF2BP2 IRF2BPL	1.71e-04	3	142	2	PF11261
Domain	VWF_type-D	MUC5B MUC2 MUC4	2.24e-04	16	142	3	IPR001846
Domain	VWFD	MUC5B MUC2 MUC4	2.24e-04	16	142	3	PS51233
Domain	VWD	MUC5B MUC2 MUC4	2.24e-04	16	142	3	SM00216
Domain	VWD	MUC5B MUC2 MUC4	2.24e-04	16	142	3	PF00094
Domain	Dishevelled	DVL1P1 DVL1	3.41e-04	4	142	2	PF02377
Domain	Dishevelled_fam	DVL1P1 DVL1	3.41e-04	4	142	2	IPR008339
Domain	Dishevelled_protein_dom	DVL1P1 DVL1	3.41e-04	4	142	2	IPR003351
Domain	Laminin_domII	LAMA2 LAMA5	5.65e-04	5	142	2	IPR010307
Domain	Laminin_aI	LAMA2 LAMA5	5.65e-04	5	142	2	IPR009254
Domain	Laminin_I	LAMA2 LAMA5	5.65e-04	5	142	2	PF06008
Domain	Laminin_II	LAMA2 LAMA5	5.65e-04	5	142	2	PF06009
Domain	SPOC_C	PHF3 SPEN	8.44e-04	6	142	2	IPR012921
Domain	WxxW_domain	MUC5B MUC2	8.44e-04	6	142	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC2	8.44e-04	6	142	2	PF13330
Domain	SPOC	PHF3 SPEN	8.44e-04	6	142	2	PF07744
Domain	Znf_FYVE_PHD	PCLO ZMYND8 KMT2C PHF3 ZFYVE26 RIMS2	9.13e-04	147	142	6	IPR011011
Domain	PDZ	DLG5 SHROOM3 DVL1P1 PCLO DVL1 RIMS2	1.05e-03	151	142	6	PS50106
Domain	PDZ	DLG5 SHROOM3 DVL1P1 PCLO DVL1 RIMS2	1.09e-03	152	142	6	IPR001478
Domain	Rab_bind	RGPD4 RGPD3	1.18e-03	7	142	2	PF16704
Domain	GCC2_Rab_bind	RGPD4 RGPD3	1.18e-03	7	142	2	IPR032023
Domain	DIX	DVL1P1 DVL1	1.18e-03	7	142	2	PF00778
Domain	DIX	DVL1P1 DVL1	1.18e-03	7	142	2	IPR001158
Domain	DIX	DVL1P1 DVL1	1.18e-03	7	142	2	PS50841
Domain	DAX	DVL1P1 DVL1	1.18e-03	7	142	2	SM00021
Domain	EGF_LAM_2	HSPG2 LAMA2 LAMA5	1.50e-03	30	142	3	PS50027
Domain	EGF_LAM_1	HSPG2 LAMA2 LAMA5	1.50e-03	30	142	3	PS01248
Domain	TPR-like_helical_dom	RGPD4 RANBP2 CCNF ZC3H7A RGPD3 TRAPPC10 GPSM1	2.06e-03	233	142	7	IPR011990
Domain	EGF_Lam	HSPG2 LAMA2 LAMA5	2.36e-03	35	142	3	SM00180
Domain	Laminin_EGF	HSPG2 LAMA2 LAMA5	2.36e-03	35	142	3	PF00053
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC12 MUC1 MUC4 MUC20	6.88e-10	16	97	6	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC12 MUC1 MUC4 MUC20	1.06e-09	17	97	6	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC1 MUC2 MUC4 MUC20	4.53e-09	21	97	6	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC12 MUC1 MUC4 MUC20	8.34e-09	23	97	6	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC12 MUC1 MUC4 MUC20	1.87e-08	26	97	6	M27483
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC1 MUC2 MUC4 MUC20	3.37e-06	60	97	6	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC12 MUC1 MUC4 MUC20	4.09e-06	62	97	6	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC12 MUC1 MUC4 MUC20	7.05e-06	68	97	6	M27303
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	HSPG2 MUC16 MUC5B MUC12 MUC1 MUC4 MUC20	5.73e-05	143	97	7	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC5B MUC1 MUC2 MUC4 MUC20	1.04e-04	109	97	6	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC5B MUC12 MUC1 MUC4 MUC20	1.15e-04	111	97	6	M27416
Pathway	REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT	CTAGE9 GBF1 SEC31B MIA2 CTAGE8 SEC16A TRAPPC10	1.57e-04	168	97	7	MM14785
Pathway	BIOCARTA_RANBP2_PATHWAY	RGPD4 RANBP2 RGPD3	2.39e-04	18	97	3	MM1549
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 MUC5B MUC12 MUC1 MUC4 MUC20	4.06e-04	140	97	6	M27484
Pathway	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	CTAGE9 GBF1 SEC31B MIA2 CTAGE8 SEC16A TRAPPC10	4.83e-04	202	97	7	MM15650
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 SHROOM3 GBF1 RHBDF1 ESYT1 DVL1 FBRSL1 LAMA5 IRS1 ANKLE1 MLXIP WNK1 MICALL1 HIVEP3 KMT2C NCOR2 PHLDB1 MAP1S SLC45A3 CTDP1 SEC16A DISP2 ZFYVE26 CACNA1H ULK1 SNAPC4 CAMSAP1 ARRDC2 SPEN MED13 RAI1 PCNT	1.18e-17	1105	151	32	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MIIP ATXN2L DLG5 SHROOM3 SETX GBF1 ESYT1 BAG3 IRS1 MLXIP WNK1 MICALL1 ARFGEF3 FAM171A1 PHLDB1 ALMS1 ATXN1 PHF3 PLEKHG3 STARD9 SEC16A PLEKHA1 MACF1 CAMSAP1	4.86e-13	861	151	24	36931259
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC5B MUC12 MUC1 MUC2 MUC4 MUC20	7.73e-13	18	151	7	18834073
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TSPOAP1 POGZ BCL11A MLXIP ARFGEF3 CRACD PHLDB1 SRGAP3 PHF3 STARD9 SEC16A MACF1 DISP2 CACNA1H ULK1 SPEN PCNT	3.03e-12	407	151	17	12693553
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MYCN IRF2BP2 ATXN2L RANBP2 GBF1 BAG3 ZMYND8 POGZ SCAF4 PAPOLG MICALL1 NCOR2 MAP1S ANAPC1 PHF3 CTDP1 SEC16A TRAPPC10 IRF2BPL SNAPC4 SPEN MED13	3.41e-12	774	151	22	15302935
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATXN2L DLG5 SETX VPS72 ENTR1 FBRSL1 WNK1 PAPOLG ARFGEF3 ZC3H7A NCOR2 ALMS1 ANAPC1 SEC16A MACF1 SPEN PCNT	9.00e-10	588	151	17	38580884
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC1 MUC2 MUC4	1.70e-09	5	151	4	11062147
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RGPD4 RANBP2 BAG3 ZMYND8 DVL1 POGZ NCOR2 ALMS1 ANAPC1 RGPD3 SEC16A CAMSAP1 PCNT NPAT	4.69e-09	418	151	14	34709266
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RGPD4 RANBP2 SHROOM3 SGIP1 ZNF618 BCL11A GRM5 FAM171A1 NCOR2 DLGAP3 ANAPC1 SRGAP3 RGPD3 SEC16A MACF1 CAMSAP1 TNS1 RAI1 PCNT	4.33e-08	963	151	19	28671696
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SHROOM3 GBF1 TSPOAP1 ZMYND8 WNK1 NCOR2 MIA2 MAP1S IRF2BPL CAMSAP1 SPEN PCNT MGRN1	5.64e-08	430	151	13	35044719
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	GBF1 WNK1 KMT2C PHLDB1 ALMS1 SRGAP3 PHF3 SEC16A MACF1 PCNT	5.95e-08	225	151	10	12168954
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RGPD4 SLC12A6 RANBP2 PCLO FAM47B ATP10B CTAGE6 DCC ZC3H7A MIA2 SACS STARD9 RGPD3 CTAGE8 CTAGE15 MACF1 ULK1 CTAGE4 RIMS2 SPEN MED13 RAI1 PCNT	7.22e-08	1442	151	23	35575683
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC1 MUC4	8.02e-08	3	151	3	23053434
Pubmed	Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice.	MUC1 MUC2 MUC4	8.02e-08	3	151	3	24714692
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4 MUC20	8.02e-08	3	151	3	30236127
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12 MUC20	8.02e-08	3	151	3	26770020
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC1 MUC4	8.02e-08	3	151	3	27483328
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC1 MUC4	8.02e-08	3	151	3	24939955
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC1 MUC4	8.02e-08	3	151	3	17592322
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC1 MUC4	8.02e-08	3	151	3	35879412
Pubmed	A human MAP kinase interactome.	RANBP2 SETX BAG3 POGZ MUC12 WNK1 ZC3H7A KMT2C ATXN1 SIMC1 MACF1 MUC1 TNS1	2.30e-07	486	151	13	20936779
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ESYT1 ATP10B SACS MACF1 ULK1 RIMS2 MTUS2	3.09e-07	101	151	7	9872452
Pubmed	Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.	MUC5B MUC1 MUC2	3.20e-07	4	151	3	25638393
Pubmed	Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.	MUC5B MUC1 MUC2	3.20e-07	4	151	3	22269464
Pubmed	Mea6 controls VLDL transport through the coordinated regulation of COPII assembly.	CTAGE9 MIA2 CTAGE8	3.20e-07	4	151	3	27311593
Pubmed	Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance.	CTAGE9 MIA2 CTAGE8	3.20e-07	4	151	3	33718348
Pubmed	Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes.	CTAGE9 MIA2 CTAGE8	3.20e-07	4	151	3	12586826
Pubmed	Mucin expression pattern in pancreatic diseases: findings from EUS-guided fine-needle aspiration biopsies.	MUC1 MUC2 MUC4	3.20e-07	4	151	3	21647207
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC1 MUC4	3.20e-07	4	151	3	39024979
Pubmed	MEA6 Deficiency Impairs Cerebellar Development and Motor Performance by Tethering Protein Trafficking.	CTAGE9 MIA2 CTAGE8	3.20e-07	4	151	3	31244610
Pubmed	Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites.	CTAGE9 MIA2 CTAGE8	3.20e-07	4	151	3	21807889
Pubmed	Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis.	MUC5B MUC1 MUC2	3.20e-07	4	151	3	21596555
Pubmed	Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon.	MUC1 MUC2 MUC4	3.20e-07	4	151	3	18198997
Pubmed	Interaction network of human early embryonic transcription factors.	RANBP2 FBRSL1 POGZ BCL11A KMT2C NCOR2 ALMS1 ATXN1 SEC16A SPEN RAI1	4.32e-07	351	151	11	38297188
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DLG5 SHROOM3 SETX ZNF280C FBRSL1 LAMA5 POGZ MICALL1 KMT2C RIMS2 MED13 RAI1 MGRN1	5.98e-07	529	151	13	14621295
Pubmed	Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry.	CTAGE9 MIA2 CTAGE8	7.97e-07	5	151	3	19131326
Pubmed	Differential expression of MUC genes in endometrial and cervical tissues and tumors.	MUC5B MUC1 MUC2	7.97e-07	5	151	3	16188033
Pubmed	MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.	MUC1 MUC2 MUC4	7.97e-07	5	151	3	16475027
Pubmed	Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease.	MUC2 MUC4 MUC20	7.97e-07	5	151	3	17058067
Pubmed	cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.	CTAGE9 MIA2 CTAGE4	7.97e-07	5	151	3	12839582
Pubmed	Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota.	MUC1 MUC2 MUC4	7.97e-07	5	151	3	18035521
Pubmed	Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis.	CTAGE9 MIA2 CTAGE8	7.97e-07	5	151	3	18630941
Pubmed	Characterization and expression pattern of the novel MIA homolog TANGO.	CTAGE9 MIA2 CTAGE8	7.97e-07	5	151	3	15183315
Pubmed	Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development.	CTAGE9 MIA2 CTAGE8	7.97e-07	5	151	3	38439956
Pubmed	A tissue-specific atlas of mouse protein phosphorylation and expression.	CTAGE9 MIA2 CTAGE8	7.97e-07	5	151	3	21183079
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	IRF2BP2 ENTR1 POGZ NCOR2 SPEN RAI1	1.20e-06	78	151	6	28611094
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	IRF2BP2 DLG5 NCOR2 ALMS1 ATXN1 SEC16A CAMSAP1 SPEN	1.54e-06	184	151	8	32908313
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC16 MUC5B MUC2	1.59e-06	6	151	3	19110483
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	DLG5 RANBP2 SHROOM3 SETX RHBDF1 VPS72 MRPS18B ESYT1 ZMYND8 LAMA5 SCAF4 CRACD ZC3H7A KMT2C ANAPC1 PHF3 PLEKHG3 RGPD3 MACF1 SPEN MED13	2.22e-06	1497	151	21	31527615
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	DLG5 RANBP2 ESYT1 DVL1 ALMS1 SEC16A PLEKHA1 MACF1 CAMSAP1	2.44e-06	263	151	9	34702444
Pubmed	Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	9037092
Pubmed	Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	11353387
Pubmed	Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	30944974
Pubmed	Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	38838144
Pubmed	Retina-specifically expressed novel subtypes of bovine cyclophilin.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	7559465
Pubmed	Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	17372272
Pubmed	Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	38657106
Pubmed	Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	21205196
Pubmed	Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	18949001
Pubmed	Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	25187515
Pubmed	Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	8603673
Pubmed	Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	26632511
Pubmed	Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	24403063
Pubmed	Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	23818861
Pubmed	cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice.	CTAGE9 MIA2 CTAGE8	2.77e-06	7	151	3	29133483
Pubmed	Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	23536549
Pubmed	Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	12191015
Pubmed	Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	22821000
Pubmed	Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.	RGPD4 RANBP2 RGPD3	2.77e-06	7	151	3	20682751
Pubmed	BCOR modulates transcriptional activity of a subset of glucocorticoid receptor target genes involved in cell growth and mobility.	IRF2BP2 FBRSL1 NCOR2 SEC16A	3.39e-06	24	151	4	33722704
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	RGPD4 RANBP2 VPS72 POGZ KMT2C RGPD3 SEC16A	3.70e-06	146	151	7	23892456
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DLG5 ENTR1 ARFGEF3 ALMS1 SCML1 SEC16A MACF1 CAMSAP1	3.96e-06	209	151	8	36779422
Pubmed	Human transcription factor protein interaction networks.	IRF2BP2 HSPG2 VPS72 ATXN7L1 MRPS18B ENTR1 ZMYND8 FBRSL1 POGZ BCL11A SCAF4 KMT2C NCOR2 ALMS1 ATXN1 PAX8 SEC16A IRF2BPL SPEN NPAT	4.10e-06	1429	151	20	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SLC12A6 ATXN2L ADCY4 AMPH SGIP1 PCLO BCL11A GRM5 CRACD DLGAP3 PHLDB1 MAP1S SACS SRGAP3 PRKAA1 SEC16A TRAPPC10 MACF1 TNS1 MTUS2	4.18e-06	1431	151	20	37142655
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	AMPH PCLO GRM5 DLGAP3 SACS SRGAP3 PHF3 MACF1 RIMS2	4.19e-06	281	151	9	28706196
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RGPD4 RANBP2 RGPD3	4.42e-06	8	151	3	21670213
Pubmed	Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.	RGPD4 RANBP2 RGPD3	4.42e-06	8	151	3	27412403
Pubmed	Mice lacking Ran binding protein 1 are viable and show male infertility.	RGPD4 RANBP2 RGPD3	4.42e-06	8	151	3	21310149
Pubmed	The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.	RGPD4 RANBP2 RGPD3	4.42e-06	8	151	3	22262462
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RGPD4 RANBP2 RGPD3	4.42e-06	8	151	3	28745977
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ATXN2L VPS72 BAG3 DVL1 POGZ SCAF4 KMT2C ALMS1 ANAPC1 PHF3 SEC16A SPEN	5.46e-06	549	151	12	38280479
Pubmed	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	RGPD4 RANBP2 RGPD3	6.61e-06	9	151	3	18394993
Pubmed	Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.	CTAGE9 MIA2 CTAGE8	6.61e-06	9	151	3	18342301
Pubmed	Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.	RGPD4 RANBP2 RGPD3	6.61e-06	9	151	3	28100513
Pubmed	Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.	RGPD4 RANBP2 RGPD3	6.61e-06	9	151	3	17887960
Pubmed	The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.	RGPD4 RANBP2 RGPD3	6.61e-06	9	151	3	11553612
Pubmed	The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.	RGPD4 RANBP2 RGPD3	6.61e-06	9	151	3	10601307
Pubmed	The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.	RGPD4 RANBP2 RGPD3	6.61e-06	9	151	3	9733766
Pubmed	Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.	RGPD4 RANBP2 RGPD3	6.61e-06	9	151	3	28877029
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	DLG5 PCLO LAMA5 PLEKHG3 MED13 MGRN1	6.85e-06	105	151	6	9628581
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	RGPD4 RANBP2 SGIP1 PCLO RGPD3 MACF1 RIMS2 PURG	8.24e-06	231	151	8	16452087
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	IRF2BP2 NCOR2 IRF2BPL SPEN	8.57e-06	30	151	4	26593974
Pubmed	The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.	RGPD4 RANBP2 RGPD3	9.41e-06	10	151	3	27160050
Pubmed	Parkin ubiquitinates and promotes the degradation of RanBP2.	RGPD4 RANBP2 RGPD3	9.41e-06	10	151	3	16332688
Pubmed	Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.	RGPD4 RANBP2 RGPD3	9.41e-06	10	151	3	8857542
Pubmed	Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability.	RGPD4 RANBP2 RGPD3	9.41e-06	10	151	3	21859863
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	RGPD4 ATXN2L RANBP2 AMPH SGIP1 TSPOAP1 STXBP5L PCLO DVL1 GRM5 ARFGEF3 DLGAP3 MAP1S SRGAP3 RGPD3 MACF1 CAMSAP1	1.01e-05	1139	151	17	36417873
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SLC12A6 HSPG2 RANBP2 LAMA2 PCDH12 WNK1 RNF167 ALMS1 ATXN1 MACF1 MED13	1.21e-05	497	151	11	23414517
Pubmed	RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.	RGPD4 RANBP2 RGPD3	1.29e-05	11	151	3	17069463
Pubmed	An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.	RGPD4 RANBP2 RGPD3	1.29e-05	11	151	3	35771867
Interaction	TOP3B interactions	MYCN HSPG2 SHROOM3 GBF1 RHBDF1 ESYT1 DVL1 FBRSL1 LAMA5 IRS1 ANKLE1 MLXIP WNK1 MICALL1 CCNF HIVEP3 ZC3H7A KMT2C NCOR2 PHLDB1 MAP1S SLC45A3 CTDP1 SEC16A DISP2 ZFYVE26 CACNA1H ULK1 SNAPC4 CAMSAP1 ARRDC2 SPEN MED13 RAI1 PCNT	3.64e-10	1470	148	35	int:TOP3B
Interaction	YWHAH interactions	MIIP ATXN2L DLG5 SHROOM3 SETX GBF1 ESYT1 BAG3 IRS1 MLXIP WNK1 MICALL1 CCNF ARFGEF3 FAM171A1 PHLDB1 ALMS1 ATXN1 PHF3 PLEKHG3 STARD9 PRKAA1 SEC16A TRAPPC10 PLEKHA1 MACF1 CAMSAP1 RIMS2 PCNT	1.69e-09	1102	148	29	int:YWHAH
Interaction	CTAGE1 interactions	CTAGE6 MIA2 CTAGE8 CTAGE15 CTAGE4	4.88e-09	10	148	5	int:CTAGE1
Interaction	ZYX interactions	DLG5 SHROOM3 GBF1 ENTR1 BAG3 MLXIP WNK1 CCNF CRACD ALMS1 ATXN1 SEC16A MACF1 CAMSAP1 PCNT	2.11e-08	329	148	15	int:ZYX
Interaction	YWHAZ interactions	MIIP MYCN ATXN2L DLG5 SHROOM3 GBF1 ESYT1 BAG3 IRS1 MLXIP WNK1 MICALL1 CCNF FAM171A1 CRACD PHLDB1 ATXN1 SRGAP3 PHF3 PLEKHG3 STARD9 SIMC1 PRKAA1 PLEKHA1 MACF1 ULK1 CAMSAP1 TNS1 PCNT	8.96e-08	1319	148	29	int:YWHAZ
Interaction	YWHAG interactions	MIIP MYCN ATXN2L DLG5 SHROOM3 GBF1 ESYT1 BAG3 IRS1 MLXIP WNK1 MICALL1 CCNF FAM171A1 CRACD PHLDB1 ALMS1 ATXN1 PHF3 PLEKHG3 STARD9 SIMC1 SEC16A TRAPPC10 PLEKHA1 MACF1 ULK1 CAMSAP1	1.02e-07	1248	148	28	int:YWHAG
Interaction	YWHAE interactions	MIIP MYCN ATXN2L DLG5 SHROOM3 GBF1 ESYT1 BAG3 IRS1 MLXIP WNK1 MICALL1 CCNF FAM171A1 CRACD NCOR2 DLGAP3 PHLDB1 ATXN1 SRGAP3 PLEKHG3 PRKAA1 PLEKHA1 MACF1 ULK1 CAMSAP1 RIMS2 ARHGAP45	1.17e-07	1256	148	28	int:YWHAE
Interaction	YWHAB interactions	MIIP MYCN ATXN2L DLG5 SHROOM3 GBF1 ESYT1 BAG3 IRS1 MLXIP WNK1 MICALL1 CCNF FAM171A1 PHLDB1 ATXN1 PHF3 PLEKHG3 STARD9 PRKAA1 TRAPPC10 PLEKHA1 MACF1 CAMSAP1	3.69e-07	1014	148	24	int:YWHAB
Interaction	FMR1 interactions	MYCN ATXN2L RANBP2 BAG3 ZMYND8 BCL11A CCNF FAM171A1 ZC3H7A NCOR2 DLGAP3 ANAPC1 PRKAA1 MACF1 TNS1 PCNT	2.16e-06	536	148	16	int:FMR1
Interaction	STIL interactions	DLG5 ENTR1 BAG3 CCNF ALMS1 SEC16A OC90 PCNT NPAS1	1.16e-05	190	148	9	int:STIL
Interaction	FBXO42 interactions	DLG5 WNK1 ARFGEF3 ZC3H7A NCOR2 ALMS1 ANAPC1 SEC16A MACF1 PCNT	2.23e-05	259	148	10	int:FBXO42
Interaction	TBXT interactions	IRF2BP2 FBRSL1 POGZ KMT2C NCOR2 ATXN1 SPEN	2.39e-05	116	148	7	int:TBXT
Interaction	SYNE3 interactions	DLG5 RANBP2 SHROOM3 ESYT1 ENTR1 NCOR2 MIA2 ALMS1 ANAPC1 SEC16A MACF1 CAMSAP1 PCNT	2.49e-05	444	148	13	int:SYNE3
Interaction	AGAP2 interactions	PCLO GRM5 DLGAP3 SACS SRGAP3 PHF3 PRKAA1 MACF1 RIMS2	2.56e-05	210	148	9	int:AGAP2
Interaction	PXN interactions	DLG5 ENTR1 BAG3 DVL1 BCL2 MICALL1 ALMS1 SEC16A MACF1 CAMSAP1 PCNT	3.73e-05	334	148	11	int:PXN
Interaction	PAX2 interactions	FBRSL1 POGZ KMT2C NCOR2 ATXN1 PAX8	3.85e-05	85	148	6	int:PAX2
Interaction	RGPD2 interactions	RGPD4 RANBP2 BCL2 RGPD3	4.30e-05	27	148	4	int:RGPD2
Interaction	SFN interactions	MIIP ATXN2L SHROOM3 GBF1 IRS1 WNK1 FAM171A1 PHLDB1 ALMS1 ATXN1 PHF3 PLEKHG3 PRKAA1 PLEKHA1 MACF1 CAMSAP1	5.10e-05	692	148	16	int:SFN
Interaction	CIAO1 interactions	ZNF280C DVL1 IRS1 CCNF FAM171A1 PHLDB1 MIA2 ATXN1 SEC16A NPAS1	5.63e-05	289	148	10	int:CIAO1
Interaction	KDM1A interactions	MYCN DLG5 RANBP2 ENTR1 ZNF280C BAG3 ZMYND8 DVL1 POGZ NCOR2 ALMS1 ATXN1 ANAPC1 SRGAP3 PLEKHG3 SEC16A CAMSAP1 PCNT NPAT	6.15e-05	941	148	19	int:KDM1A
Interaction	GOLGA1 interactions	DLG5 GBF1 ENTR1 ARFGEF3 ALMS1 SEC16A MACF1 PCNT	6.33e-05	183	148	8	int:GOLGA1
Interaction	AP2B1 interactions	MYCN DLG5 AMPH SGIP1 ENTR1 WNK1 CCNF ALMS1 ATXN1 SEC16A PCNT	1.00e-04	373	148	11	int:AP2B1
Interaction	AURKB interactions	MYCN DLG5 RANBP2 SETX GBF1 ENTR1 BAG3 WNK1 CCNF MAP1S PLEKHG3 SCML1 CTDP1 SEC16A MACF1 SNAPC4	1.54e-04	761	148	16	int:AURKB
Interaction	CTAGE4 interactions	MIA2 CTAGE4	1.60e-04	3	148	2	int:CTAGE4
Cytoband	9q34.3	ENTR1 SEC16A SNAPC4 CAMSAP1 GPSM1	2.79e-05	106	151	5	9q34.3
Cytoband	7q35	CTAGE6 CTAGE8 CTAGE15 CTAGE4	3.37e-05	55	151	4	7q35
Cytoband	Ensembl 112 genes in cytogenetic band chr7q35	CTAGE6 CTAGE8 CTAGE15 CTAGE4	6.92e-05	66	151	4	chr7q35
Cytoband	17q22-q23	TSPOAP1 MED13	1.60e-04	6	151	2	17q22-q23
Cytoband	Xp21.1	FAM47A FAM47C FAM47B	1.94e-04	34	151	3	Xp21.1
Cytoband	18q21.3	BCL2 DCC	5.80e-04	11	151	2	18q21.3
Cytoband	Ensembl 112 genes in cytogenetic band chr9q34	SETX ENTR1 SEC16A SNAPC4 CAMSAP1 GPSM1	7.58e-04	325	151	6	chr9q34
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	AMH CRLF1 MUC16 ANKLE1 MAP1S PWWP3A MPND ARRDC2 ARHGAP45	1.36e-03	797	151	9	chr19p13
Cytoband	2q12.3	RGPD4 RANBP2	1.41e-03	17	151	2	2q12.3
Cytoband	19p13.11	ANKLE1 MAP1S ARRDC2	1.83e-03	73	151	3	19p13.11
GeneFamily	CD molecules\|Mucins	MUC16 MUC5B MUC12 MUC1 MUC2 MUC4 MUC20	2.26e-11	21	107	7	648
GeneFamily	CTAGE family	CTAGE9 CTAGE6 MIA2 CTAGE8 CTAGE15 CTAGE4	1.79e-10	15	107	6	907
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	RGPD4 RANBP2 ZC3H7A RGPD3 GPSM1	6.05e-04	115	107	5	769
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	BCL2 GRM5 WNK1 ARFGEF3 SACS TNS1	7.26e-04	181	107	6	694
GeneFamily	PDZ domain containing	DLG5 SHROOM3 PCLO DVL1 RIMS2	2.10e-03	152	107	5	1220
GeneFamily	Laminin subunits	LAMA2 LAMA5	2.20e-03	12	107	2	626
GeneFamily	Non-clustered protocadherins	PCDH12 PCDH17	2.20e-03	12	107	2	21
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	RANBP2 AMPH SETX GBF1 ZMYND8 IRS1 FAM171A1 NCOR2 MIA2 SACS ATXN1 PHF3 MACF1 SPEN MED13 PCNT NPAT	8.68e-06	856	150	17	M4500
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	MYCN RHBDF1 VPS72 ENTR1 FBRSL1 POGZ ARFGEF3 CRACD SEC16A ULK1 MGRN1	1.43e-05	385	150	11	M2840
Coexpression	BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	CTAGE9 ESYT1 BCL2 MIA2 CTAGE8	1.45e-05	54	150	5	MM1195
Coexpression	ZHONG_PFC_C3_ASTROCYTE	MYCN SETX TSPOAP1 PCLO FBRSL1 SEC31B ARFGEF3 NCOR2 SNAPC4 NPAS1 MGRN1	1.58e-05	389	150	11	M39102
Coexpression	GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP	ZMYND8 MLXIP FAM171A1 ATXN1 PLEKHG3 MACF1 CAMSAP1 MUC2	1.87e-05	197	150	8	M9569
Coexpression	GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP	RHBDF1 POGZ PCDH12 RNF167 PHLDB1 MIA2 ARRDC2 TNS1	2.08e-05	200	150	8	M7872
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL	AMPH STXBP5L PCLO BCL2 PCDH17 ARFGEF3 HIVEP3 CACNA1H RIMS2	2.53e-05	268	150	9	M45696
Coexpression	TERAO_AOX4_TARGETS_HG_UP	CTAGE9 MIA2 CTAGE8 TRAPPC10	3.27e-05	32	150	4	MM922
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	RGPD4 RANBP2 CRLF1 RGPD3	3.71e-05	33	150	4	MM477
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL	DLG5 AMPH PCLO IRS1 PCDH17 ARFGEF3 FAM171A1 SRGAP3 LRP11 CACNA1H RIMS2	3.86e-05	429	150	11	M45694
Coexpression	BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	AMH NPBWR2 DVL1 IRS1 PAX8 MUC2 NPAS1	3.92e-05	160	150	7	M9556
Coexpression	NABA_ECM_AFFILIATED	MUC16 MUC5B MUC12 MUC1 MUC2 MUC4 MUC20	5.76e-05	170	150	7	M5880
Coexpression	HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN	HSPG2 SYT17 ESAM SRGAP3	5.87e-05	37	150	4	M41058
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	TSPOAP1 PCLO ZMYND8 LAMA5 BCL11A DCC GRM5 SEC31B PCDH17 ARFGEF3 HIVEP3 SRGAP3 PLEKHA1 IRF2BPL RIMS2 MUC2 MTUS2 RAI1	6.50e-05	1106	150	18	M39071
Coexpression	BRACHAT_RESPONSE_TO_METHOTREXATE_DN	CTAGE9 BCL2 MIA2 CTAGE8	6.54e-05	38	150	4	MM1161
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	AMPH TSPOAP1 BCL11A DCC SEC31B ARFGEF3 HIVEP3 CRACD IRF2BPL RIMS2 MTUS2	7.94e-05	465	150	11	M39066
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	GBF1 WNK1 KMT2C SRGAP3 MACF1 ULK1 MED13	8.26e-05	180	150	7	M8239
Coexpression	GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL	ZMYND8 MUC5B ERN2 MUC4	8.85e-05	41	150	4	M39158
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	ATXN2L RANBP2 SETX ESYT1 BCL2 WNK1 VSIR PAPOLG HIVEP3 KMT2C RNF167 SACS ATXN1 SRGAP3 PHF3 TRAPPC10 MACF1 SPEN ARHGAP45 MED13 NPAT	1.23e-04	1492	150	21	M40023
Coexpression	FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP	CTAGE9 DLG5 ZNF280C BCL2 CTAGE6 BCL11A ADGRG4 FCRL1 ANAPC1 CTAGE15 CTAGE4 MUC20	1.49e-04	587	150	12	M40869
Coexpression	GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP	RNF167 PHLDB1 SIMC1 PLEKHA1 ZFYVE26 ULK1 RAI1	1.49e-04	198	150	7	M9035
Coexpression	GSE40655_FOXO1_KO_VS_WT_NTREG_UP	IRS1 KMT2C PHF3 SNAPC4 ARHGAP45 RAI1 PCNT	1.59e-04	200	150	7	M9439
Coexpression	GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP	SETX FBRSL1 ESAM STARD9 PLEKHA1 ARRDC2 PURG	1.59e-04	200	150	7	M7147
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLG5 MUC16 ATP10B MUC5B ERN2 SRGAP3 MACF1 ULK1 MUC4 RAI1	5.96e-10	179	151	10	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADCY4 SETX ESAM PCDH12 PCDH17 FAM171A1 KMT2C MACF1 PCNT	2.90e-08	200	151	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Entopeduncular-Endothelial\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	HSPG2 ADCY4 ESYT1 LAMA5 ESAM ZIC5 ELN TNS1	2.67e-07	188	151	8	94774652fd42bad5012356672ffac8b6d2c22d37
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 MUC16 MUC5B ERN2 ARFGEF3 SRGAP3 RIMS2 MUC4	3.53e-07	195	151	8	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	NS-critical-d_07-13\|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 ATP10B ERN2 ARFGEF3 LRP11 MUC1 MUC4 MUC20	3.96e-07	198	151	8	a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCell	5'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRABD2A ATP10B MUC5B MUC12 MLXIP ERN2 MUC1 MUC4	3.96e-07	198	151	8	08982f9e37591261975ddff9b9a6a59ba836fc0f
ToppCell	5'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRABD2A ATP10B MUC5B MUC12 MLXIP ERN2 MUC1 MUC4	3.96e-07	198	151	8	45a1287dc618a37949978b297e2b782ea80a7f39
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ATP10B MUC5B ERN2 ARFGEF3 MUC1 MUC4 MUC20	4.11e-07	199	151	8	7223f853335492ca617dbec3e4b6872a8a463a45
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ATP10B MUC5B ERN2 ARFGEF3 MUC1 MUC4 MUC20	4.11e-07	199	151	8	e03bdc7cb825e287f41b834ec6061d23c1c03b04
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 PCLO MUC16 MUC5B ERN2 CHRM3 ARFGEF3 SRGAP3	4.27e-07	200	151	8	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	ADCY4 SETX ESAM PCDH12 PCDH17 FAM171A1 PLEKHA1 MACF1	4.27e-07	200	151	8	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	IRF2BP2 RHBDF1 BCL2 BCL11A FCRL1 PLEKHA1 MACF1	1.82e-06	169	151	7	c3a6179a64589a370108fea809b157839347759c
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	IL34 MYCN PCLO MUC16 ATP10B MUC4 MUC20	2.21e-06	174	151	7	9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B MUC12 ERN2 ARFGEF3 MUC1 MUC2 MUC4	2.30e-06	175	151	7	019ea30ac55748463d7917abf3d3f0e804189bfd
ToppCell	droplet-Liver-LIVER-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 ESAM ANKLE1 ITPRIP DISP2 GPSM1 PURG	2.39e-06	176	151	7	4d2fb51e71bed0d72f3d7f89d395744860885a5f
ToppCell	droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 ESAM ANKLE1 ITPRIP DISP2 GPSM1 PURG	2.39e-06	176	151	7	4880fa20b50eb10358e08567e08559ef2954f237
ToppCell	droplet-Liver-LIVER-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 ESAM ANKLE1 ITPRIP DISP2 GPSM1 PURG	2.39e-06	176	151	7	fcdddd949ca05b3ecde240db9e38296a6eab2d6a
ToppCell	metastatic_Lymph_Node-Endothelial_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IL34 HSPG2 ADCY4 SGIP1 PCDH12 PCDH17 ELN	2.48e-06	177	151	7	71bf5d4bc67bda37a0499e5ec01af7dd5254041d
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B MUC12 ERN2 ARFGEF3 MUC1 MUC2 MUC4	2.57e-06	178	151	7	9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SHROOM3 ATP10B ERN2 DISP2 MUC1 MUC2 MUC4	2.67e-06	179	151	7	c833ded1f9e87be2ba2037820d92a389560b711c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ADCY4 ESAM PCDH12 PCDH17 STARD9 ITPRIP	2.77e-06	180	151	7	16728b9a1c52097e3a460534be71a476ecc54f0f
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HSPG2 ADCY4 ZNF280C PCDH12 PCDH17 CCNF UBAP1L	2.77e-06	180	151	7	40d4838a0ccb10d5e49266bc8a0037d27b75ccc2
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	HSPG2 ADCY4 ESAM PCDH12 CHRM3 VSIR PCDH17	3.57e-06	187	151	7	29b2e2be26a9d72b154760e47acf61cfe2f45fa7
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	HSPG2 ADCY4 ESAM PCDH12 CHRM3 VSIR PCDH17	3.69e-06	188	151	7	b66f1f08827dd6c48583d871f9f33ea41e48bfb2
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Proximal_secretory_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	MUC16 MUC5B ERN2 ARFGEF3 MUC1 MUC4 MUC20	3.69e-06	188	151	7	07705bed928683470a52c8ccfa40ffb9a0971318
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HSPG2 ADCY4 ESAM PCDH12 CHRM3 VSIR PCDH17	3.96e-06	190	151	7	7ba2be2630183df86de21689289a8620a4cd507e
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	MUC16 MUC5B ERN2 ARFGEF3 SRGAP3 MUC1 MUC4	3.96e-06	190	151	7	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ATP10B MUC5B ERN2 ARFGEF3 SRGAP3 MUC4	4.54e-06	194	151	7	e0228f593c3493175962a4817500d4337ddc4e88
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SGIP1 RHBDF1 LAMA2 HIVEP3 ELN GPSM1 TNS1	4.54e-06	194	151	7	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ADCY4 ESAM PCDH12 CHRM3 VSIR PCDH17 ARFGEF3	4.54e-06	194	151	7	53a5e8863d79a052dff0758f389be5ac3883c721
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SHROOM3 ATP10B ERN2 ARFGEF3 MUC1 MUC2 MUC4	4.70e-06	195	151	7	c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBF1 PCLO ARFGEF3 LRP11 DISP2 GPSM1 MUC4	4.70e-06	195	151	7	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	Goblet_1\|World / shred by cell class for nasal brushing	MUC16 ATP10B VSIR ARFGEF3 MUC1 MUC4 MUC20	4.70e-06	195	151	7	d9e4889a2e7b7c97c07c15b043b77837739462e4
ToppCell	NS-critical-LOC-Epithelial-Secretory\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HSPG2 MUC16 ATP10B MUC5B IRS1 ERN2 MUC4	4.70e-06	195	151	7	b0d782eeee30c797b4da9b3be29b864983fd9e71
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 ATP10B MUC5B ERN2 ARFGEF3 MUC1 MUC4	4.70e-06	195	151	7	b9e8f405f6d837bb39b615836d3e2df349737c0e
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SHROOM3 ATP10B ERN2 ARFGEF3 MUC1 MUC2 MUC4	4.70e-06	195	151	7	219c5d0cde7f6082755154f54db221413ec555cb
ToppCell	PCW_13-14-Endothelial\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	HSPG2 ADCY4 ESAM PCDH12 CHRM3 VSIR PCDH17	4.86e-06	196	151	7	7286de29a34e13834cd6347c67a1443897fa4ade
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AMPH STXBP5L PCLO GRM5 CHRM3 RIMS2 MTUS2	4.86e-06	196	151	7	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	5'-Adult-LargeIntestine-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B ERN2 ARFGEF3 DISP2 MUC1 MUC2 MUC4	4.86e-06	196	151	7	847b3377f463bfded046eec63cc1b547f3dc33c1
ToppCell	PCW_10-12-Endothelial-Endothelial_mature\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HSPG2 ADCY4 ESAM PCDH12 CHRM3 PCDH17 ARFGEF3	4.86e-06	196	151	7	481d79bdaec069ad2746a28d39eeee8d3edf7305
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	MIIP IRF2BP2 ATXN2L BCL2 WNK1 KMT2C ARHGAP45	4.86e-06	196	151	7	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	PCW_10-12-Endothelial\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HSPG2 ADCY4 ESAM PCDH12 CHRM3 VSIR PCDH17	4.86e-06	196	151	7	2c60dcf9132ee156f25b349e2ac5313709def4f6
ToppCell	distal-Epithelial-Goblet\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MUC16 ATP10B MUC5B ERN2 MUC2 MUC4 MUC20	5.02e-06	197	151	7	da1ed7303cc9cb2d205c0e5c49c52544d3540951
ToppCell	distal-3-Epithelial-Goblet\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MUC16 ATP10B MUC5B ERN2 MUC2 MUC4 MUC20	5.02e-06	197	151	7	a00784ccfb1de6a96b91e2a8a2889b69f31a33da
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRABD2A ATP10B MUC5B MLXIP CHRM3 MUC1 MUC4	5.02e-06	197	151	7	c0250509836f1be04f5e54386191d7bb1e1da652
ToppCell	5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRABD2A MUC5B MUC12 MLXIP ERN2 MUC1 MUC4	5.02e-06	197	151	7	e14a0e8a893c72356afc5508e3531ae0b23bfe16
ToppCell	5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B ERN2 ARFGEF3 DISP2 MUC1 MUC2 MUC4	5.02e-06	197	151	7	d624f3a105b19f19a0dd253ce8de3ed13adc1f01
ToppCell	5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRABD2A MUC5B MUC12 MLXIP ERN2 MUC1 MUC4	5.02e-06	197	151	7	19cf283537c853fa902852e7b8ac1139729a931a
ToppCell	distal-Epithelial-Goblet-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MUC16 ATP10B MUC5B ERN2 MUC2 MUC4 MUC20	5.02e-06	197	151	7	3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ADCY4 ESAM CHRM3 PCDH17 HIVEP3 ITPRIP	5.19e-06	198	151	7	07701c73137947ed4a27e225975329235bbb8734
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ADCY4 ESAM CHRM3 PCDH17 HIVEP3 ITPRIP	5.19e-06	198	151	7	31ba87552be97c9b78c9e82f98e96699ccb19824
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AMPH STXBP5L PCLO GRM5 CHRM3 RIMS2 MTUS2	5.19e-06	198	151	7	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	3'-Adult\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRABD2A BAG3 ATP10B MUC5B MUC12 MUC1 MUC4	5.19e-06	198	151	7	302adb42089ff22fffc4f01af572ca2e151f7ce7
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AMPH STXBP5L PCLO GRM5 CHRM3 RIMS2 MTUS2	5.19e-06	198	151	7	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AMPH STXBP5L PCLO GRM5 CHRM3 RIMS2 MTUS2	5.19e-06	198	151	7	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	10x5'v1-week_12-13-Endothelial-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 ADCY4 LAMA5 ESAM PCDH12 CHRM3 PCDH17	5.19e-06	198	151	7	122215d9288533ad03562cf777e846504863df9a
ToppCell	BL-critical-LOC-Epithelial-Secretory_LYPD2\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PCLO MUC16 MUC5B ERN2 MUC1 MUC2 MUC4	5.19e-06	198	151	7	484d16aaa601a1e11b871b0475dd01a2de1a29ce
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AMPH STXBP5L PCLO GRM5 CHRM3 RIMS2 MTUS2	5.19e-06	198	151	7	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	10x5'v1-week_12-13-Endothelial\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 ADCY4 LAMA5 ESAM PCDH12 CHRM3 PCDH17	5.19e-06	198	151	7	307dd09e6bc820a148f3000f18dae7aedba4be0b
ToppCell	moderate-Epithelial-Secretory\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MUC16 ATP10B ERN2 ARFGEF3 MUC1 MUC4 MUC20	5.19e-06	198	151	7	7d96d7105a849c7280ce87bd76ce130ac47384fd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ADCY4 ESAM CHRM3 PCDH17 HIVEP3 ITPRIP	5.19e-06	198	151	7	440af8f90c7afa1c07000806bcf9110b70f489fb
ToppCell	5'-Adult-Distal_Rectal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRABD2A MUC5B MUC12 ERN2 ELN MUC1 MUC4	5.19e-06	198	151	7	db26c20321f9ab102d6484f22ddb2bde684067b1
ToppCell	5'-Adult-Distal_Rectal-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRABD2A MUC5B MUC12 MLXIP ERN2 MUC1 MUC4	5.19e-06	198	151	7	9c0535099750698daac5d6b4d39fb19fecf4ffde
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AMPH STXBP5L PCLO GRM5 CHRM3 RIMS2 MTUS2	5.19e-06	198	151	7	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Tracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 MUC16 ATP10B MUC5B ARFGEF3 MUC1 MUC20	5.37e-06	199	151	7	ef1a0c278c23614fd6a3218a9733abe6ecd6f686
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ATP10B MUC5B ERN2 MUC1 MUC4 MUC20	5.37e-06	199	151	7	ec1e110671e7725f752163c7241dbbf638dec2b2
ToppCell	(04)_Interm._basal>secr.\|World / shred by cell type by condition	MUC16 ATP10B MUC5B ARFGEF3 MUC1 MUC4 MUC20	5.37e-06	199	151	7	ed399244433f781fc291a9bff16825b8a3ca294f
ToppCell	distal-Epithelial-Mucous-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ATP10B MUC5B ERN2 ARFGEF3 MUC1 MUC4 MUC20	5.37e-06	199	151	7	0af89ef40807fc4ad79ab82a2186ab6e866c6931
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	MYCN IRF2BP2 ZNF618 POGZ WNK1 PCDH17 SCML1	5.37e-06	199	151	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ATP10B MUC5B ERN2 MUC1 MUC4 MUC20	5.37e-06	199	151	7	a706ad5cd5e0dc8d7e925a05e45b07d35963f294
ToppCell	distal-Epithelial-Mucous\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ATP10B MUC5B ERN2 ARFGEF3 MUC1 MUC4 MUC20	5.37e-06	199	151	7	a7fe7b792d696f369ad0310a772160a1729ef223
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SGIP1 LAMA2 PHLDB1 PLEKHG3 STARD9 CACNA1H TNS1	5.55e-06	200	151	7	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DLG5 PCLO LAMA5 SRGAP3 MUC1 MUC4 MUC20	5.55e-06	200	151	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 ERN2 ARFGEF3 SRGAP3 MUC1 MUC4 MUC20	5.55e-06	200	151	7	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	AMPH STXBP5L PCLO GRM5 CHRM3 RIMS2 MTUS2	5.55e-06	200	151	7	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYCN MUC16 MUC5B ERN2 CHRM3 ARFGEF3 SRGAP3	5.55e-06	200	151	7	ed093626a9cac7531a2bf02f6e345c5e84b8c060
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SGIP1 LAMA2 PHLDB1 PLEKHG3 STARD9 CACNA1H TNS1	5.55e-06	200	151	7	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADCY4 SETX ESAM PCDH12 PCDH17 FAM171A1 MACF1	5.55e-06	200	151	7	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SGIP1 LAMA2 PHLDB1 PLEKHG3 STARD9 CACNA1H TNS1	5.55e-06	200	151	7	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DLG5 PCLO MUC16 SRGAP3 MUC1 MUC4 MUC20	5.55e-06	200	151	7	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	pdx-Tumor_cells-T4\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MIIP MUC16 ESAM BCL2 RNF167 MUC4	1.34e-05	152	151	6	7ccc56b79c499dd48dab8e2d936edca5223b9356
ToppCell	facs-Lung-EPCAM-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESAM CPA2 ANKLE1 FAM170A PCDH17 DISP2	1.55e-05	156	151	6	bb64bf520cb74897a01c64924a85a1550df2b801
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TSPOAP1 MRPS18B SEC31B PCDH17 PLEKHG3 MROH7	1.79e-05	160	151	6	8374ae912337947b2cc8d17d5840f306361fe1ff
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 MUC5B ERN2 SRGAP3 MUC4 MUC20	1.86e-05	161	151	6	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	TSPOAP1 ESAM PCDH12 CHRM3 VSIR PCDH17	1.99e-05	163	151	6	d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b
ToppCell	Endothelial-B-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	MYCN ADCY4 SGIP1 PCDH12 ZIC5 ELN	2.44e-05	169	151	6	95c617143e1fbdd1d55a93ffdcc210e0be37cf2f
ToppCell	5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B ERN2 ARFGEF3 DISP2 MUC2 MUC4	2.61e-05	171	151	6	48125d825ca2d7ef34564250f5b47d2a579e03c9
ToppCell	metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IL34 HSPG2 ADCY4 SGIP1 PCDH12 PCDH17	2.87e-05	174	151	6	d551bc29afef071adf4c9bb80345352ec33441d8
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYCN PCLO CHRM3 PCDH17 CRACD MROH7	2.87e-05	174	151	6	66df78280f657978c4a568010ae7d7943869af90
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PCDH17 HIVEP3 FAM171A1 MACF1 ELN TNS1	2.97e-05	175	151	6	282f09bbdfa70d93b3f66591dcfb84c5ee0268c7
ToppCell	(03)_Secretory\|World / shred by cell type and Timepoint	MUC16 MUC5B SLC45A3 MUC1 MUC4 MUC20	3.06e-05	176	151	6	cb7b1945788196ca79007f0768b6576ec885a0e5
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 ESAM PCDH12 PCDH17 FAM171A1 FCRLB	3.06e-05	176	151	6	3494ffa8555e6edf4b1250e10434bae9b73ec845
ToppCell	droplet-Liver-Npc-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 ESAM PCDH12 PCDH17 FAM171A1 FCRLB	3.06e-05	176	151	6	d43f6b7828b98e1dab7b726a5f99499d65a7db80
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PCLO PHLDB1 MIA2 PWWP3A ULK1 SPEN	3.16e-05	177	151	6	946803293a7955116c80f403e99e4093e798ca3f
ToppCell	3'_v3-Lung-Hematopoietic_progenitors\|Lung / Manually curated celltypes from each tissue	MYCN PCLO CHRM3 PCDH17 EZHIP GPSM1	3.26e-05	178	151	6	c7895ba2e2e93b26da91faa2a3bf9d070dd4c3bd
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	BCL11A HIVEP3 FCRL1 SIMC1 PLEKHA1 ARRDC2	3.26e-05	178	151	6	71ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell	3'_v3-Lung-Hematopoietic_progenitors-HSC-MPP\|Lung / Manually curated celltypes from each tissue	MYCN PCLO CHRM3 PCDH17 EZHIP GPSM1	3.37e-05	179	151	6	2c03b82ec9b4dee2501752b8d83e7028f0aaed77
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 ATP10B MUC5B ERN2 MUC4 MUC20	3.37e-05	179	151	6	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	COVID-19_Mild-Hematopoietic_SC-HSPC\|COVID-19_Mild / Disease group, lineage and cell class	MYCN HSPG2 CHRM3 CRACD SLC45A3 GPSM1	3.37e-05	179	151	6	19fcf48f5e02e4cb2b328efb4502f337e1282f72
ToppCell	COVID-19_Mild-Hematopoietic_SC\|COVID-19_Mild / Disease group, lineage and cell class	MYCN HSPG2 CHRM3 CRACD SLC45A3 GPSM1	3.37e-05	179	151	6	50a073166e34bcfa52a62c4dafb3aef724e0fa8e
Drug	Nefopam hydrochloride [23327-57-3]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MIIP SLC12A6 HSPG2 DLG5 ERN2 SCAF4 MIA2 ABCB8 ARHGAP45	4.46e-06	193	146	9	3627_DN
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	MIIP HSPG2 AMH CRLF1 WNK1 PLEKHG3 SNAPC4 RIMS2 MUC1	4.65e-06	194	146	9	3859_DN
Drug	Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A	HSPG2 MUC5B MLXIP SCAF4 ALMS1 PHF3 ABCB8 CACNA1H CAMSAP1	5.06e-06	196	146	9	4423_DN
Drug	Sulfathiazole [72-14-0]; Down 200; 15.6uM; PC3; HT_HG-U133A	MIIP ZMYND8 PCDH12 ERN2 PLEKHG3 PWWP3A MRNIP ULK1 MUC1	5.27e-06	197	146	9	4183_DN
Drug	Letrozole [112809-51-5]; Up 200; 14uM; PC3; HT_HG-U133A	ATXN2L ATXN7L1 SYT17 BCL2 DCC PCDH17 SRGAP3 PLEKHG3 CAMSAP1	5.27e-06	197	146	9	4240_UP
Drug	Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	HSPG2 SYT17 ZMYND8 MICALL1 PHLDB1 MIA2 PHF3 PLEKHG3 MUC1	5.49e-06	198	146	9	1491_DN
Drug	Chlorhexidine [55-56-1]; Down 200; 8uM; MCF7; HT_HG-U133A	MIIP ZMYND8 BCL2 ERN2 MAP1S PHF3 PLEKHG3 SNAPC4 NPAT	5.49e-06	198	146	9	1525_DN
Drug	Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; HL60; HT_HG-U133A	ATXN2L ZMYND8 ERN2 WNK1 SCAF4 CCNF MIA2 PHF3 MRNIP	5.72e-06	199	146	9	2550_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	ATXN7L1 WNK1 MICALL1 MIA2 ALMS1 ATXN1 PHF3 SPEN	3.20e-05	190	146	8	4306_DN
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	MIIP SYT17 BCL11A ERN2 HIVEP3 PHLDB1 PLEKHG3 TNS1	3.58e-05	193	146	8	5919_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	ZMYND8 MLXIP DNAAF2 ALMS1 MAP1S CTDP1 MRNIP ULK1	3.58e-05	193	146	8	5566_DN
Drug	Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A	MIIP DLG5 ERN2 WNK1 SCAF4 MICALL1 MIA2 CACNA1H	3.72e-05	194	146	8	3604_DN
Drug	Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	AMH AMPH CHRM3 PAX8 PLEKHG3 CACNA1H ELN SPEN	3.72e-05	194	146	8	6835_UP
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	MIIP ATXN2L ATXN7L1 WNK1 PCDH17 NCOR2 PLEKHG3 MRNIP	3.72e-05	194	146	8	3674_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	TSPOAP1 ZMYND8 ATP10B MLXIP ERN2 WNK1 PHF3 ABCB8	3.72e-05	194	146	8	2223_UP
Drug	Ethamsylate [2624-44-4]; Up 200; 15.2uM; PC3; HT_HG-U133A	CRLF1 ATP10B BCL2 ERN2 PAPOLG PAX8 PLEKHG3 CAMSAP1	3.86e-05	195	146	8	4576_UP
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; PC3; HT_HG-U133A	DLG5 POGZ ERN2 HIVEP3 ATXN1 PHF3 SNAPC4 CAMSAP1	3.86e-05	195	146	8	5814_DN
Drug	Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A	CRLF1 CPA2 ATP10B PCDH12 MIA2 ELN CAMSAP1 TNS1	4.00e-05	196	146	8	5000_UP
Drug	Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A	HSPG2 ERN2 MICALL1 HIVEP3 PHLDB1 MIA2 PHF3 CACNA1H	4.00e-05	196	146	8	3333_DN
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	BCL2 WNK1 SCAF4 PAX8 PHF3 CTDP1 CACNA1H SNAPC4	4.00e-05	196	146	8	3256_UP
Drug	Contact Lens Solutions	MUC16 MUC1	4.08e-05	2	146	2	ctd:D018639
Drug	Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	CRLF1 ERN2 HIVEP3 MIA2 PHF3 PLEKHG3 CAMSAP1 MUC1	4.14e-05	197	146	8	6519_DN
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	MIIP AMH CRLF1 MLXIP CHRM3 PHF3 ELN TNS1	4.14e-05	197	146	8	3837_DN
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A	ATXN2L HSPG2 ATP10B FAM171A1 NCOR2 PHLDB1 SRGAP3 CACNA1H	4.14e-05	197	146	8	4134_UP
Drug	Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A	CRLF1 ZMYND8 LAMA5 POGZ ERN2 PLEKHG3 CTDP1 CACNA1H	4.14e-05	197	146	8	3572_DN
Drug	Adrenosterone [382-45-6]; Up 200; 13.4uM; PC3; HT_HG-U133A	ATXN2L STXBP5L ATP10B PCDH12 WNK1 HIVEP3 PHLDB1 ELN	4.14e-05	197	146	8	5045_UP
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; HL60; HG-U133A	ZMYND8 SEC31B WNK1 SCAF4 PLEKHG3 SCML1 PWWP3A ZFYVE26	4.14e-05	197	146	8	1726_UP
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; PC3; HT_HG-U133A	ATXN2L CRLF1 NCOR2 PHLDB1 PAX8 ELN CAMSAP1 RIMS2	4.30e-05	198	146	8	6651_UP
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A	MIIP ZMYND8 POGZ ERN2 WNK1 PHF3 CTDP1 CACNA1H	4.30e-05	198	146	8	3294_DN
Drug	Avermectin B1 [71751-41-2]; Up 200; 4.8uM; HL60; HT_HG-U133A	CRLF1 LAMA2 CCNF NCOR2 ELN MUC1 MUC2 NPAS1	4.30e-05	198	146	8	2519_UP
Drug	Flecainide acetate [54143-56-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	STXBP5L BCL2 POGZ BCL11A WNK1 CHRM3 SNAPC4 MUC1	4.30e-05	198	146	8	3761_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Down 200; 15uM; MCF7; HT_HG-U133A	SETX GBF1 ZMYND8 SCAF4 ALMS1 TRAPPC10 MRNIP NPAT	4.30e-05	198	146	8	5325_DN
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A	DLG5 PCDH12 ERN2 CCNF HIVEP3 BTN3A3 PLEKHG3 MUC1	4.30e-05	198	146	8	4194_DN
Drug	Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A	SYT17 ATP10B PCDH12 WNK1 SCAF4 SRGAP3 PLEKHG3 ELN	4.45e-05	199	146	8	5048_UP
Drug	Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	AMH AMPH ZMYND8 LAMA2 CPA2 ERN2 HIVEP3 RIMS2	4.45e-05	199	146	8	5066_UP
Drug	Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; HL60; HT_HG-U133A	ZMYND8 ERN2 SEC31B WNK1 PAPOLG ATXN1 CTDP1 TNS1	4.45e-05	199	146	8	1277_DN
Drug	Flucytosine [2022-85-7]; Down 200; 31uM; PC3; HT_HG-U133A	MIIP RHBDF1 BCL11A HIVEP3 ALMS1 PHF3 PWWP3A CAMSAP1	4.61e-05	200	146	8	6690_DN
Drug	PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A	MIIP TSPOAP1 PCLO HIVEP3 NCOR2 PLEKHG3 ZFYVE26 TNS1	4.61e-05	200	146	8	5917_DN
Drug	PHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A	LAMA2 CPA2 ATP10B PAX8 PHF3 PLEKHG3 SPEN MUC2	4.61e-05	200	146	8	3773_UP
Drug	Boric Acids	MUC16 MUC1	1.22e-04	3	146	2	ctd:D001888
Drug	SAHA; Down 200; 10uM; HL60; HT_HG-U133A	DLG5 ZMYND8 BCL2 BCL11A MICALL1 ARHGAP45 TNS1	1.39e-04	175	146	7	1161_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	SETX ZMYND8 IRS1 CHRM3 PHF3 CAMSAP1 NPAT	1.65e-04	180	146	7	4541_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	SETX ZMYND8 IRS1 CCNF DNAAF2 PHF3 NPAT	1.89e-04	184	146	7	2321_DN
Drug	0175029-0000 [211245-78-2]; Down 200; 10uM; PC3; HT_HG-U133A	SETX ZMYND8 POGZ CCNF DNAAF2 MAP1S NPAT	2.02e-04	186	146	7	6875_DN
Drug	Anisomycin [22862-76-6]; Down 200; 15uM; PC3; HT_HG-U133A	BCL11A CCNF DNAAF2 FAM171A1 ALMS1 PWWP3A CAMSAP1	2.09e-04	187	146	7	6764_DN
Drug	fullerene C60	SLC12A6 ATXN2L SHROOM3 CRLF1 TSPOAP1 ENTR1 CPA2 MUC5B PCDH17 PAPOLG CCNF TRAPPC10 PWWP3A IRF2BPL ELN ULK1 ARRDC2 GPSM1 MUC4 TNS1 MED13 PURG	2.26e-04	1498	146	22	ctd:C069837
Drug	Bisacodyl [603-50-9]; Down 200; 11uM; MCF7; HT_HG-U133A	SETX SYT17 ZMYND8 CCNF DNAAF2 SACS MRNIP	2.31e-04	190	146	7	3297_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	ATXN7L1 ZMYND8 POGZ WNK1 PHLDB1 SNAPC4 MUC1	2.31e-04	190	146	7	4582_DN
Drug	Prostaglandin E1; Up 200; 10uM; PC3; HT_HG-U133A	MIIP BCL11A MIA2 PLEKHG3 CTDP1 TRAPPC10 MRNIP	2.31e-04	190	146	7	6555_UP
Drug	Digitoxigenin [143-62-4]; Down 200; 10.6uM; PC3; HT_HG-U133A	MIIP HSPG2 BCL11A MIA2 PHF3 ARHGAP45 TNS1	2.38e-04	191	146	7	4217_DN
Drug	Methamphetamine	ATXN2L HSPG2 ADCY4 GBF1 RHBDF1 ATXN7L1 SYT17 ZMYND8 BCL2 GRM5 MICALL1 DNAAF2 NCOR2 PHLDB1 MIA2 MACF1 ARRDC2 RIMS2 GPSM1 TNS1 PCNT	2.42e-04	1401	146	21	ctd:D008694
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A	MIIP SETX POGZ WNK1 ALMS1 PHF3 SNAPC4	2.46e-04	192	146	7	2292_DN
Drug	Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	SLC12A6 SCAF4 ALMS1 PLEKHG3 PWWP3A SNAPC4 NPAT	2.54e-04	193	146	7	1811_DN
Drug	Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; PC3; HT_HG-U133A	ZMYND8 PCDH12 ERN2 PHF3 PLEKHG3 ABCB8 MUC1	2.54e-04	193	146	7	4202_DN
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	SLC12A6 CRLF1 PCLO HIVEP3 MIA2 ATXN1 RIMS2	2.62e-04	194	146	7	4424_DN
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	PCLO CCNF PHLDB1 CACNA1H RIMS2 MUC1 ARHGAP45	2.62e-04	194	146	7	4411_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	MIIP BCL2 ERN2 WNK1 MICALL1 PLEKHG3 MACF1	2.62e-04	194	146	7	5641_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A	ATXN2L HSPG2 MUC5B POGZ SCAF4 ZC3H7A NCOR2	2.62e-04	194	146	7	433_DN
Drug	Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A	HSPG2 PAPOLG NCOR2 ATXN1 PHF3 CACNA1H CAMSAP1	2.62e-04	194	146	7	4139_UP
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	MIIP SYT17 CCNF MAP1S MRNIP ULK1 MUC1	2.70e-04	195	146	7	4533_DN
Drug	Dicumarol [66-76-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MLXIP SCAF4 MIA2 CACNA1H ELN MUC1 TNS1	2.70e-04	195	146	7	3423_UP
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; HL60; HT_HG-U133A	AMH CRLF1 CHRM3 PAX8 CAMSAP1 MUC2 NPAS1	2.70e-04	195	146	7	2544_UP
Drug	Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HG-U133A	MIIP ZMYND8 LAMA2 NCOR2 PHLDB1 ELN PROP1	2.70e-04	195	146	7	1884_UP
Drug	Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; PC3; HT_HG-U133A	ATXN2L SYT17 MUC5B PHLDB1 RIMS2 MUC2 TNS1	2.70e-04	195	146	7	4232_UP
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	ATXN2L HSPG2 ZMYND8 WNK1 PAPOLG ALMS1 MGRN1	2.79e-04	196	146	7	1323_UP
Drug	Merbromin [129-16-8]; Up 200; 5uM; MCF7; HT_HG-U133A	HSPG2 STXBP5L WNK1 CHRM3 ABCB8 CAMSAP1 TNS1	2.79e-04	196	146	7	4722_UP
Drug	Harpagoside [19210-12-9]; Down 200; 8uM; HL60; HT_HG-U133A	PCLO ZMYND8 HIVEP3 ALMS1 SCML1 SNAPC4 TNS1	2.79e-04	196	146	7	2935_DN
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; HL60; HT_HG-U133A	MIIP HSPG2 GBF1 PCLO BCL2 DNAAF2 PLEKHG3	2.79e-04	196	146	7	2922_DN
Drug	Carcinine [56897-53-1]; Up 200; 22uM; PC3; HT_HG-U133A	SYT17 BCL2 BCL11A PCDH17 SRGAP3 CAMSAP1 TNS1	2.79e-04	196	146	7	4225_UP
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; PC3; HT_HG-U133A	HSPG2 ATXN7L1 ATP10B BCL2 ERN2 WNK1 HIVEP3	2.79e-04	196	146	7	3762_DN
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; PC3; HT_HG-U133A	SYT17 MUC5B ERN2 CCNF BTN3A3 ARHGAP45 TNS1	2.79e-04	196	146	7	4500_DN
Drug	Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A	ZMYND8 SCAF4 HIVEP3 PLEKHG3 CTDP1 CACNA1H CAMSAP1	2.79e-04	196	146	7	3567_DN
Drug	Benzthiazide [91-33-8]; Up 200; 9.2uM; PC3; HT_HG-U133A	HSPG2 LAMA2 ATP10B PAX8 ELN RIMS2 MUC1	2.79e-04	196	146	7	6607_UP
Drug	nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A	MIIP ATXN7L1 ATP10B PCDH17 SCAF4 PHF3 RIMS2	2.79e-04	196	146	7	5583_UP
Drug	Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A	ZMYND8 WNK1 ALMS1 PHF3 TRAPPC10 PLEKHA1 CACNA1H	2.79e-04	196	146	7	3473_UP
Drug	Chlorpropamide [94-20-2]; Up 200; 14.4uM; MCF7; HT_HG-U133A	MIIP MYCN ATXN2L HSPG2 ATP10B PHLDB1 PAX8	2.79e-04	196	146	7	3210_UP
Drug	Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; PC3; HT_HG-U133A	MYCN AMH SYT17 WNK1 PCDH17 HIVEP3 MUC1	2.87e-04	197	146	7	5060_UP
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; PC3; HT_HG-U133A	HSPG2 SYT17 ATP10B BCL2 HIVEP3 SRGAP3 ELN	2.87e-04	197	146	7	5747_UP
Drug	Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A	MIIP ATXN2L HSPG2 MAP1S PLEKHG3 CAMSAP1 MUC1	2.87e-04	197	146	7	3235_DN
Drug	Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A	GBF1 SYT17 MICALL1 PHLDB1 MRNIP SNAPC4 ARHGAP45	2.87e-04	197	146	7	7412_UP
Drug	Torsemide [56211-40-6]; Up 200; 11.4uM; PC3; HT_HG-U133A	MIIP STXBP5L ZMYND8 PCDH12 PHLDB1 PLEKHG3 MUC1	2.87e-04	197	146	7	5057_UP
Drug	Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; PC3; HT_HG-U133A	AMPH ATP10B MLXIP ELN CAMSAP1 RIMS2 MUC2	2.87e-04	197	146	7	4658_UP
Drug	Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A	MLXIP PCDH17 HIVEP3 PHLDB1 ALMS1 CACNA1H ELN	2.87e-04	197	146	7	2880_UP
Drug	Danazol [17230-88-5]; Up 200; 11.8uM; HL60; HG-U133A	MIIP ZMYND8 LAMA2 ERN2 PHF3 ELN MUC1	2.87e-04	197	146	7	2038_UP
Drug	Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A	ATXN2L LAMA2 BCL2 PAX8 CAMSAP1 MUC4 TNS1	2.87e-04	197	146	7	6091_UP
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; PC3; HT_HG-U133A	ATXN2L ATXN7L1 SYT17 BCL2 PCDH17 SRGAP3 PLEKHG3	2.87e-04	197	146	7	4226_UP
Drug	Ethamivan [304-84-7]; Up 200; 18uM; MCF7; HT_HG-U133A	PCDH12 ERN2 ALMS1 PRKAA1 MACF1 RIMS2 MUC4	2.87e-04	197	146	7	7021_UP
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A	PCLO WNK1 PHLDB1 CTDP1 PWWP3A SNAPC4 MUC1	2.87e-04	197	146	7	5453_DN
Drug	Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A	SYT17 POGZ CHRM3 MIA2 PLEKHG3 CAMSAP1 MUC1	2.87e-04	197	146	7	3182_DN
Drug	Lorglumide sodium salt [97964-56-2]; Up 200; 8.4uM; MCF7; HT_HG-U133A	ATXN2L BCL11A PAPOLG FAM171A1 NCOR2 SRGAP3 PROP1	2.87e-04	197	146	7	5619_UP
Drug	Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; PC3; HT_HG-U133A	CRLF1 ZMYND8 BCL11A BTN3A3 MIA2 PWWP3A TNS1	2.87e-04	197	146	7	7262_UP
Drug	Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; PC3; HT_HG-U133A	POGZ PCDH12 WNK1 PHLDB1 ALMS1 SRGAP3 MUC1	2.87e-04	197	146	7	5054_UP
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	MIIP CRLF1 PCLO CHRM3 MICALL1 PLEKHG3 CACNA1H	2.87e-04	197	146	7	3877_DN
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	AMH ZMYND8 MUC5B SCAF4 PHLDB1 MIA2 CACNA1H	2.87e-04	197	146	7	3247_UP
Drug	fluphenazine dihydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	GBF1 MUC5B BTN3A3 MIA2 MAP1S ATXN1 MRNIP	2.87e-04	197	146	7	1237_UP
Drug	Alprostadil [745-65-3]; Down 200; 11.2uM; PC3; HT_HG-U133A	AMH BCL2 ERN2 NCOR2 PAX8 SNAPC4 RIMS2	2.96e-04	198	146	7	4099_DN
Drug	Spaglumic acid [4910-46-7]; Up 200; 13.2uM; HL60; HT_HG-U133A	HSPG2 ERN2 PAPOLG PHF3 PLEKHG3 SNAPC4 CAMSAP1	2.96e-04	198	146	7	2962_UP
Drug	Iobenguane sulfate; Up 200; 10.8uM; MCF7; HT_HG-U133A	ATXN2L BCL11A MLXIP ALMS1 PAX8 SRGAP3 RIMS2	2.96e-04	198	146	7	2878_UP
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A	AMPH ATXN7L1 ZMYND8 BCL2 TRAPPC10 CACNA1H TNS1	2.96e-04	198	146	7	4422_UP
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	HSPG2 SYT17 CHRM3 MAP1S PLEKHG3 MUC1 ARHGAP45	2.96e-04	198	146	7	3175_DN
Disease	allergic conjunctivitis (is_marker_for)	MUC1 MUC2 MUC4	1.28e-05	10	142	3	DOID:11204 (is_marker_for)
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC1 MUC2 MUC4	1.46e-05	64	142	5	DOID:4947 (is_marker_for)
Disease	central nervous system disease (implicated_via_orthology)	IRF2BP2 SEC31B IRF2BPL	5.84e-05	16	142	3	DOID:331 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	VPS72 LAMA2 BCL2 BCL11A WNK1 MICALL1 MIA2 SRGAP3 ABCB8 PRKAA1 MROH7 MACF1 ZFYVE26 SPEN TNS1 PURG	6.29e-05	1074	142	16	C0006142
Disease	Intellectual Disability	POGZ BCL11A DCC PCDH12 KMT2C SACS SRGAP3 MACF1 MED13 RAI1	6.46e-05	447	142	10	C3714756
Disease	neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures (implicated_via_orthology)	IRF2BP2 IRF2BPL	6.88e-05	3	142	2	DOID:0081327 (implicated_via_orthology)
Disease	intestinal disease (implicated_via_orthology)	BCL2 MUC2	1.37e-04	4	142	2	DOID:5295 (implicated_via_orthology)
Disease	mucositis (biomarker_via_orthology)	MUC2 MUC4	2.28e-04	5	142	2	DOID:0080178 (biomarker_via_orthology)
Disease	mucinous adenocarcinoma (is_marker_for)	MUC2 MUC4	2.28e-04	5	142	2	DOID:3030 (is_marker_for)
Disease	DiGeorge syndrome (is_implicated_in)	DVL1P1 DVL1	2.28e-04	5	142	2	DOID:11198 (is_implicated_in)
Disease	R-6-hydroxywarfarin measurement	SHROOM3 ATXN7L1 GRM5 NCOR2 SPEN	2.32e-04	114	142	5	EFO_0803327
Disease	eosinophil count	LINC02881 ATXN7L1 SYT17 ZMYND8 BCL2 DCST2 ERN2 WNK1 HIVEP3 NCOR2 ATXN1 SLC45A3 ANAPC1 SEC16A CACNA1H ARHGAP45 MUC2 RAI1	2.95e-04	1488	142	18	EFO_0004842
Disease	verbal-numerical reasoning measurement	ATXN2L DCC ATXN1 PURG NPAS1	4.40e-04	131	142	5	EFO_0008394
Disease	common bile duct neoplasm (is_marker_for)	MUC1 MUC4	6.32e-04	8	142	2	DOID:4608 (is_marker_for)
Disease	retinal detachment, retinal break	DLG5 LAMA2 GRM5	6.38e-04	35	142	3	EFO_0005773, EFO_0010698
Disease	household income	GBF1 SGIP1 BCL11A DCC PCDH17 ATXN1 PURG	6.99e-04	304	142	7	EFO_0009695
Disease	alanine measurement	IL34 FBRSL1 MLXIP SCAF4	8.04e-04	86	142	4	EFO_0009765
Disease	unipolar depression, bipolar disorder	PCLO ZMYND8 DCC GRM5 STARD9	9.70e-04	156	142	5	EFO_0003761, MONDO_0004985
Disease	cortical thickness	IL34 IRF2BP2 HSPG2 SHROOM3 VPS72 LAMA2 PCDH17 MICALL1 PHLDB1 SRGAP3 LRP11 MACF1 ELN TNS1	9.88e-04	1113	142	14	EFO_0004840
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC1	1.01e-03	10	142	2	DOID:10140 (is_marker_for)
Disease	otitis media (is_marker_for)	MUC5B MUC4	1.01e-03	10	142	2	DOID:10754 (is_marker_for)
Disease	allergic rhinitis (biomarker_via_orthology)	BCL2 MUC1	1.01e-03	10	142	2	DOID:4481 (biomarker_via_orthology)
Disease	Neurodevelopmental Disorders	POGZ HIVEP3 KMT2C SRGAP3	1.08e-03	93	142	4	C1535926
Disease	nasopharynx carcinoma (is_marker_for)	BCL2 KMT2C SPEN	1.17e-03	43	142	3	DOID:9261 (is_marker_for)
Disease	Schizophrenia	LAMA2 ESAM BCL2 BCL11A DCC GRM5 PCDH17 SRGAP3 RIMS2 RAI1 PCNT NPAS1	1.19e-03	883	142	12	C0036341
Disease	pulmonary fibrosis	MUC5B CHRM3	1.23e-03	11	142	2	EFO_0009448
Disease	Alzheimer disease, APOE carrier status	IRF2BP2 SETX DCC ZIC5	1.31e-03	98	142	4	EFO_0007659, MONDO_0004975
Disease	esophagus squamous cell carcinoma (is_implicated_in)	DCC KMT2C SPEN	1.34e-03	45	142	3	DOID:3748 (is_implicated_in)
Disease	pancreatic cancer (is_marker_for)	BAG3 MUC16 MUC1 MUC4	1.46e-03	101	142	4	DOID:1793 (is_marker_for)
Disease	lymphocyte percentage of leukocytes	GBF1 TSPOAP1 BCL2 VSIR ATXN1 FCRLB SNAPC4 ARRDC2 ARHGAP45 NPAT	1.47e-03	665	142	10	EFO_0007993
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ATXN2L ATXN1	1.47e-03	12	142	2	DOID:1441 (implicated_via_orthology)
Disease	Intestinal Neoplasms	BCL2 MUC2	1.47e-03	12	142	2	C0021841
Disease	Intestinal Cancer	BCL2 MUC2	1.47e-03	12	142	2	C0346627
Disease	cognitive function measurement	IL34 IRF2BP2 ATXN2L GBF1 ZNF618 BCL2 BCL11A DCC PCDH17 ALMS1 ATXN1 PLEKHA1 CACNA1H MUC2 PURG NPAS1	1.51e-03	1434	142	16	EFO_0008354
Disease	type 2 diabetes mellitus (implicated_via_orthology)	IRS1 BCL11A ALMS1 PRKAA1	1.69e-03	105	142	4	DOID:9352 (implicated_via_orthology)
Disease	neuroticism measurement, cognitive function measurement	ATXN2L PCLO BCL11A DCC GRM5 PCDH17 PLEKHA1 PURG RAI1	1.73e-03	566	142	9	EFO_0007660, EFO_0008354
Disease	cholangiocarcinoma (biomarker_via_orthology)	MUC1 MUC4	1.73e-03	13	142	2	DOID:4947 (biomarker_via_orthology)
Disease	monocyte count	LINC02881 TSPOAP1 BCL2 WNK1 VSIR HIVEP3 NCOR2 ATXN1 CTDP1 FCRLB ELN ARRDC2 ARHGAP45 RAI1 NPAT	1.79e-03	1320	142	15	EFO_0005091
Disease	attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder	PCLO DCC GRM5	1.92e-03	51	142	3	EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090
Disease	intelligence, self reported educational attainment	ATXN2L BCL11A DCC PCDH17	2.50e-03	117	142	4	EFO_0004337, EFO_0004784
Disease	cleft lip	AMPH MUC16 CPA2 GRM5 NCOR2 ATXN1	2.59e-03	284	142	6	EFO_0003959
Disease	Spondyloepiphyseal Dysplasia	HSPG2 BCL2	2.64e-03	16	142	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	HSPG2 BCL2	2.64e-03	16	142	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	HSPG2 BCL2	2.64e-03	16	142	2	C4551479
Disease	Schwartz-Jampel Syndrome	HSPG2 BCL2	2.64e-03	16	142	2	C0036391
Disease	Melnick-Needles Syndrome	HSPG2 BCL2	2.64e-03	16	142	2	C0025237
Disease	pain	SGIP1 LAMA2 DCC PLEKHA1 MACF1	2.64e-03	196	142	5	EFO_0003843
Disease	alcohol consumption measurement	ATXN2L DLG5 SGIP1 ZNF618 PCLO FBRSL1 DCC GRM5 MICALL1 NCOR2 DLGAP3 ALMS1 ATXN1 RIMS2	2.73e-03	1242	142	14	EFO_0007878
Disease	Moyamoya Disease	ELN PCNT	2.98e-03	17	142	2	C0026654
Disease	Van Buchem disease	HSPG2 BCL2	2.98e-03	17	142	2	C0432272
Disease	otitis media (biomarker_via_orthology)	MUC1 MUC4	2.98e-03	17	142	2	DOID:10754 (biomarker_via_orthology)
Disease	response to opioid	MUC16 GRM5 CTDP1	3.20e-03	61	142	3	EFO_0008541
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC1 MUC4	3.20e-03	61	142	3	DOID:3587 (is_marker_for)
Disease	sweet liking measurement	ATP10B DCC	3.35e-03	18	142	2	EFO_0010156
Disease	cystic fibrosis (is_marker_for)	MUC5B MUC1 MUC2	3.35e-03	62	142	3	DOID:1485 (is_marker_for)
Disease	fish consumption measurement	GRM5 MICALL1 ATXN1	3.67e-03	64	142	3	EFO_0010139
Disease	cerebral microbleeds	HSPG2 AMPH	3.73e-03	19	142	2	EFO_0010059
Disease	Osteochondrodysplasias	HSPG2 BCL2	3.73e-03	19	142	2	C0029422
Disease	Dyschondroplasias	HSPG2 BCL2	3.73e-03	19	142	2	C0013366
Disease	obesity (implicated_via_orthology)	IRS1 ALMS1 PRKAA1 SEC16A MED13	3.92e-03	215	142	5	DOID:9970 (implicated_via_orthology)
Disease	Multiple Epiphyseal Dysplasia	HSPG2 BCL2	4.13e-03	20	142	2	C0026760
Disease	end stage renal disease (implicated_via_orthology)	IRS1 BCL2	4.13e-03	20	142	2	DOID:783 (implicated_via_orthology)
Disease	schizophrenia (implicated_via_orthology)	GRM5 SRGAP3 RIMS2	4.35e-03	68	142	3	DOID:5419 (implicated_via_orthology)
Disease	Neoplastic Cell Transformation	MYCN IRS1 BCL2 MUC1	4.64e-03	139	142	4	C0007621
Disease	Parkinson disease	GBF1 SYT17 BAG3 FBRSL1 MUC12 MED13	4.71e-03	321	142	6	MONDO_0005180

Protein segments in the cluster

Peptide	Gene	Start	Entry
HSRGTEVSEPSPPVR	CTDP1	346	Q9Y5B0
SGGPPHITSSAPELR	ESYT1	941	Q9BSJ8
LSRASPATPAGHPVS	FBRSL1	786	Q9HCM7
PLETVDKHGSSASPP	ANKLE1	196	Q8NAG6
LPAHPGAEVSPSATT	BTN3A3	556	O00478
DPHRAPSDTGSLSSP	CTAGE4	586	Q8IX94
DPHRAPSDTGSLSSP	CTAGE6	586	Q86UF2
DPHRAPSDTGSLSSP	CTAGE8	586	P0CG41
DPHRAPSDTGSLSSP	CTAGE9	586	A4FU28
DPHRAPSDTGSLSSP	CTAGE15	586	A4D2H0
QTHSPSEIPLGTPSD	ADGRG4	1311	Q8IZF6
IHSPSDAGLPPGTVT	CHRM3	21	P20309
PTVPSGSFSHREKPS	ALMS1	996	Q8TCU4
KSPTTPGETAHVRVP	CPA2	56	P48052
HGDSPVSTSTPLPEK	ADCY4	496	Q8NFM4
TTHSASEPLPVGLPA	ATXN1	436	P54253
HPRTPTDPGLDSALE	CAMSAP1	1141	Q5T5Y3
VPPEASPERSCSLHS	DISP2	46	A7MBM2
PDTGETTTLPPGRHE	ARRDC2	91	Q8TBH0
AADSPLPSPAAHITT	ATXN7L1	511	Q9ULK2
VRDGFPHCPSETTPL	ATP10B	16	O94823
GPRTHSTPSIPVLTA	ATXN2L	686	Q8WWM7
PEVTPAGSAGVTHSP	AMPH	361	P49418
RSSASAIHPPGPITT	MTUS2	791	Q5JR59
DHCRGRATTPPPTTE	MUC5B	1601	Q9HC84
PVPNTTATTHGRSLP	MUC5B	3446	Q9HC84
GRSLPPSSPHTVRTA	MUC5B	3456	Q9HC84
PSSTEAPRLSSGNHP	MROH7	131	Q68CQ1
PHDRPLTASSSLAPG	RAI1	246	Q7Z5J4
PHVSRSSTPRESPCG	RANBP2	2451	P49792
GHTLIPSSAVTPPES	PAX8	156	Q06710
APGTRFPLTSAHDPD	PCDH17	146	O14917
GSSHVPSVSPPIRIE	HSPG2	2621	P98160
SPHGESADSIPAPIT	TSPOAP1	1061	O95153
FVSHLPREPSEGTPA	ITPRIP	361	Q8IWB1
EDPSSHPATPRPEFT	NPAS1	481	Q99742
AGTDTPPLATHSSRP	PCDH12	601	Q9NPG4
PRATHPVTSGSERPC	MRNIP	286	Q6NTE8
LPPESVCSSVGDSHP	NPAT	701	Q14207
RSASSHEVPPGSPRE	ANAPC1	191	Q9H1A4
SHLRPEPPETGVSHL	FAM47C	436	Q5HY64
SSVSHLRPEPPETGV	FAM47C	541	Q5HY64
SHLRPEPPETGVSHL	FAM47C	616	Q5HY64
RNATSPLTHPSPSGE	MUC16	786	Q8WXI7
SSIHPRPETSAPGAE	MUC16	1906	Q8WXI7
IPGPDHSTESPDIST	MUC16	6701	Q8WXI7
TPLPVTDASSVPTGH	MUC4	1951	Q99102
SSSGPPHETAAPKRT	NCOR2	1296	Q9Y618
PVSVPTAPEVSEESH	DCC	1396	P43146
SEFPGPLSVTSHGRP	FAM171A1	371	Q5VUB5
PLSVTSHGRPEAPGT	FAM171A1	376	Q5VUB5
PRSPSPISTLSHRAG	GRM5	1016	P41594
HSDITAPPTPGISET	KMT2C	3626	Q8NEZ4
HRSPLTAASPGELPT	ARHGAP45	91	Q92619
HTAASPALPRTTGPS	LRP11	356	Q86VZ4
TVTTPSLPAEVGSPH	MAP1S	676	Q66K74
SRHAGSPPGSVEEPS	DNAAF2	441	Q9NVR5
DSPHPVITPSRASES	MUC20	181	Q8N307
SASSDGPHPVITPSR	MUC20	196	Q8N307
GPHPVITPSRASESS	MUC20	201	Q8N307
ASSDGPHPVITPSRA	MUC20	216	Q8N307
PHPVITPSRASESSA	MUC20	221	Q8N307
SSDGPHPVITPSRAS	MUC20	236	Q8N307
SDGPHPVITPSRASE	MUC20	256	Q8N307
DGPHPVITPSRASES	MUC20	276	Q8N307
SASSDGPHPVITPSR	MUC20	291	Q8N307
GPHPVITPSRASESS	MUC20	296	Q8N307
ASSDGPHPVITPSRA	MUC20	311	Q8N307
PHPVITPSRASESSA	MUC20	316	Q8N307
SSDGPHPVITPSRAS	MUC20	331	Q8N307
DGPHPVITPSRASES	MUC20	371	Q8N307
HVPRTSIPRAPSSDE	GPSM1	481	Q86YR5
VHPTLGSGTAETRPP	ERN2	376	Q76MJ5
PDSTLRSPSSPIHEE	MGRN1	451	O60291
THLDPARLSPESAPG	EZHIP	251	Q86X51
TAPPAHGVTSAPDTR	MUC1	131	P15941
HGVTSAPDTRPAPGS	MUC1	136	P15941
TAPPAHGVTSAPDTR	MUC1	151	P15941
HGVTSAPDTRPAPGS	MUC1	156	P15941
TAPPAHGVTSAPDTR	MUC1	171	P15941
HGVTSAPDTRPAPGS	MUC1	176	P15941
TAPPAHGVTSAPDTR	MUC1	191	P15941
HGVTSAPDTRPAPGS	MUC1	196	P15941
TAPPAHGVTSAPDTR	MUC1	211	P15941
HGVTSAPDTRPAPGS	MUC1	216	P15941
TAPPAHGVTSAPDTR	MUC1	231	P15941
HGVTSAPDTRPAPGS	MUC1	236	P15941
TAPPAHGVTSAPDTR	MUC1	251	P15941
HGVTSAPDTRPAPGS	MUC1	256	P15941
TAPPAHGVTSAPDTR	MUC1	271	P15941
HGVTSAPDTRPAPGS	MUC1	276	P15941
TAPPAHGVTSAPDTR	MUC1	291	P15941
HGVTSAPDTRPAPGS	MUC1	296	P15941
TAPPAHGVTSAPDTR	MUC1	311	P15941
HGVTSAPDTRPAPGS	MUC1	316	P15941
TAPPAHGVTSAPDTR	MUC1	331	P15941
HGVTSAPDTRPAPGS	MUC1	336	P15941
TAPPAHGVTSAPDTR	MUC1	351	P15941
HGVTSAPDTRPAPGS	MUC1	356	P15941
TAPPAHGVTSAPDTR	MUC1	371	P15941
HGVTSAPDTRPAPGS	MUC1	376	P15941
TAPPAHGVTSAPDTR	MUC1	391	P15941
HGVTSAPDTRPAPGS	MUC1	396	P15941
TAPPAHGVTSAPDTR	MUC1	411	P15941
HGVTSAPDTRPAPGS	MUC1	416	P15941
TAPPAHGVTSAPDTR	MUC1	431	P15941
HGVTSAPDTRPAPGS	MUC1	436	P15941
TAPPAHGVTSAPDTR	MUC1	451	P15941
HGVTSAPDTRPAPGS	MUC1	456	P15941
TAPPAHGVTSAPDTR	MUC1	471	P15941
HGVTSAPDTRPAPGS	MUC1	476	P15941
TAPPAHGVTSAPDTR	MUC1	491	P15941
HGVTSAPDTRPAPGS	MUC1	496	P15941
TAPPAHGVTSAPDTR	MUC1	511	P15941
HGVTSAPDTRPAPGS	MUC1	516	P15941
TAPPAHGVTSAPDTR	MUC1	531	P15941
HGVTSAPDTRPAPGS	MUC1	536	P15941
TAPPAHGVTSAPDTR	MUC1	551	P15941
HGVTSAPDTRPAPGS	MUC1	556	P15941
TAPPAHGVTSAPDTR	MUC1	571	P15941
HGVTSAPDTRPAPGS	MUC1	576	P15941
TAPPAHGVTSAPDTR	MUC1	591	P15941
HGVTSAPDTRPAPGS	MUC1	596	P15941
TAPPAHGVTSAPDTR	MUC1	611	P15941
HGVTSAPDTRPAPGS	MUC1	616	P15941
TAPPAHGVTSAPDTR	MUC1	631	P15941
HGVTSAPDTRPAPGS	MUC1	636	P15941
TAPPAHGVTSAPDTR	MUC1	651	P15941
HGVTSAPDTRPAPGS	MUC1	656	P15941
TAPPAHGVTSAPDTR	MUC1	671	P15941
HGVTSAPDTRPAPGS	MUC1	676	P15941
TAPPAHGVTSAPDTR	MUC1	691	P15941
HGVTSAPDTRPAPGS	MUC1	696	P15941
TAPPAHGVTSAPDTR	MUC1	711	P15941
HGVTSAPDTRPAPGS	MUC1	716	P15941
TAPPAHGVTSAPDTR	MUC1	731	P15941
HGVTSAPDTRPAPGS	MUC1	736	P15941
TAPPAHGVTSAPDTR	MUC1	751	P15941
HGVTSAPDTRPAPGS	MUC1	756	P15941
TAPPAHGVTSAPDTR	MUC1	771	P15941
HGVTSAPDTRPAPGS	MUC1	776	P15941
TAPPAHGVTSAPDTR	MUC1	791	P15941
HGVTSAPDTRPAPGS	MUC1	796	P15941
TAPPAHGVTSAPDTR	MUC1	811	P15941
HGVTSAPDTRPAPGS	MUC1	816	P15941
TAPPAHGVTSAPDTR	MUC1	831	P15941
HGVTSAPDTRPAPGS	MUC1	836	P15941
TAPPAHGVTSAPDTR	MUC1	851	P15941
HGVTSAPDTRPAPGS	MUC1	856	P15941
TAPPAHGVTSAPDTR	MUC1	871	P15941
HGVTSAPDTRPAPGS	MUC1	876	P15941
TAPPAHGVTSAPDTR	MUC1	891	P15941
HGVTSAPDTRPAPGS	MUC1	896	P15941
TAPPAHGVTSAPDTR	MUC1	911	P15941
HGVTSAPDTRPAPGS	MUC1	916	P15941
SEHGSPLTPRVGIPS	BCL11A	201	Q9H165
PPVSLGSSSHTARLP	IRF2BPL	176	Q9H1B7
RPHGPLLPTIEDSSE	PCLO	1761	Q9Y6V0
SSIPSGLVFTHRPEP	PCLO	2491	Q9Y6V0
GPPTHTSTAPIAELT	MUC2	4196	Q02817
APESVLHAKSGPSPE	FAM214A	276	Q32MH5
SIFSPPAGTSEPHRA	FAM214B	51	Q7L5A3
TLVSSVHPEPPDTGA	FAM47B	266	Q8NA70
RVSHLHPEPPETGVS	FAM47B	291	Q8NA70
SGTTTPEHPSVIDPL	DLG5	1456	Q8TDM6
TPATTVHAPEEPDTA	MACF1	976	O94854
APSLATSPALGHPES	MICALL1	441	Q8N3F8
TPTPVLTHGPCAAES	LAMA2	2741	P24043
RPTAATTGDPAPLHD	AMH	351	P03971
TPIPPDTSERTGDHP	LRIT3	351	Q3SXY7
SPSHPPLITCTGSDV	LAMA5	1081	O15230
LGKSPSEPAHPEATT	MPND	211	Q8N594
SFRSVTPDSLGHTPP	IRS1	441	P35568
PPHQPLGSGESSSTR	IRS1	1206	P35568
EDSLHPVPAAPTLGS	OC90	426	Q02509
HPEPLDSRGSFSLPT	NPBWR2	6	P48146
TRESPPTRDVPSGHT	PCNT	3246	O95613
PSPALSRSHPRTGSV	RIMS2	1131	Q9UQ26
VTDLGHGTSSPPAPV	MLXIP	631	Q9HAP2
VTPKRSHSPSIDGTP	PAPOLG	641	Q9BWT3
PHVSRSSTPRESPCG	RGPD3	1476	A6NKT7
SSPPHSTGSVRPVRA	IL34	221	Q6ZMJ4
SPDPPTFLSTGEIHA	CCNF	546	P41002
THPERVPAGTSPCST	ENTR1	196	Q96C92
LIASPSHPTEGSPVT	FCRL1	21	Q96LA6
SPPEHSPEQGRSLST	ARFGEF3	1061	Q5TH69
AEPSSSRSVPVAHPG	CRACD	921	Q6ZU35
HISPEGPLSLSEGPS	DLGAP3	56	O95886
SSVTSARALRPPHGP	ESAM	311	Q96AP7
SSLRPEPPETGVSHL	FAM47A	221	Q5JRC9
LTSAAGDTRTPGHPP	GBF1	1741	Q92538
TDSHTDLPPPLERTG	DVL1	96	O14640
HRPPETSSATKGAPT	DCST2	736	Q5T1A1
HFAVSPGTPETTPVE	FCRLB	411	Q6BAA4
TDSHTDLPPPLERTG	DVL1P1	96	P54792
REGSPARSSTPLHSP	BAG3	276	O95817
PLGSVASVHSPPAES	CACNA1H	1961	O95180
SSPARSGEPLHALSP	CACNA1H	1986	O95180
SHPTAASTPRSERPG	CRLF1	331	O75462
REGDPSSSQHLPSTP	ELN	626	P15502
TVGSHSPPETPVLTR	ZMYND8	751	Q9ULU4
ATVALDPPSDRTSHP	SLC12A6	71	Q9UHW9
GAETSHTEPVSPIPK	SCAF4	646	O95104
PPGEESSTGLPVHIS	SACS	451	Q9NZJ4
EPVHPASLPDSSLAT	IRF2BP2	486	Q7Z5L9
KHSAPSPPVSVGSEE	PURG	151	Q9UJV8
ERSVPHSPGAPVGTS	PANK1	146	Q8TE04
TDPHRAPSDTGSLSP	MIA2	1191	Q96PC5
EEAPPASSTPHVVGS	ABCB8	116	Q9NUT2
STARLGPPPSHASAD	PWWP3A	341	Q2TAK8
PHVSRSSTPRESPCG	RGPD4	1476	Q7Z3J3
DHASAAPPSVTRSPV	SCML1	226	Q9UN30
GDSVHTASEVPLTPR	SYT17	71	Q9BSW7
PESSSPTEGRSPAHL	PLEKHG3	866	A1L390
GEHSESSTPRPRSSP	POGZ	1361	Q7Z3K3
PRSSPEETIEPESLH	POGZ	1371	Q7Z3K3
PHSAPSLGTSSLRDP	MIIP	111	Q5JXC2
TAEGLSAPHTPVTPG	RHBDF1	171	Q96CC6
DHPASERTPLLGSSP	RNF167	301	Q9H6Y7
PHSSGDVTHSPRDIP	SIMC1	331	Q8NDZ2
RSLTHPPTIAPEGSR	SETX	2471	Q7Z333
PEASASASPHTPRER	SHROOM3	971	Q8TF72
SSVSHAPPGVPGELS	SEC31B	1041	Q9NQW1
SSSIALGDPHIPTSP	STARD9	3561	Q9P2P6
SVEPATVPSIPEAHS	MED13	1056	Q9UHV7
TEPAEGLSAPSLSPH	SLC45A3	226	Q96JT2
THPGPVVHLSDSPRD	STXBP5L	206	Q9Y2K9
SPVDLTPRPGSHTIE	PRKAA1	531	Q13131
TPHPAASRDPVARTS	BCL2	56	P10415
SDAHERPPSPSLGTT	LINC02881	6	B7Z368
HGAVSATPPAPTLVS	MRPS18B	181	Q9Y676
GSECSHPEVSPSPRF	ZNF618	296	Q5T7W0
VPSGPSIPADRTVSH	SPEN	3001	Q96T58
PAPHGEARILTVTPS	SPEN	3261	Q96T58
LSPSRGFAEHSSEPP	MYCN	61	P04198
PEPERPSSRASHSSE	SEC16A	1216	O15027
DTHSPPRGLGPSIDT	SRGAP3	871	O43295
SDTSPEHVTPELTPR	SGIP1	316	Q9BQI5
PSESGRHLLSEPSTP	VSIR	271	Q9H7M9
HSLGTPEPAPRASLE	TNS1	771	Q9HBL0
DSLPGSPTVEDTPRA	FAM170A	201	A1A519
TAPHPEAGRLVPSSS	HIVEP3	1666	Q5T1R4
TSHIAETPESAPPIA	PHF3	1361	Q92576
VPAPEAVSSGHSTLP	TRABD2A	386	Q86V40
HSTLPPLVSRPGSAD	TRABD2A	396	Q86V40
TRSPSPTLGESLAPH	PHLDB1	516	Q86UU1
LLPERHPATGTPTTT	PROP1	21	O75360
VSPEHGLAPAPTTIR	UBAP1L	81	F5GYI3
PSSSVTPRHPLEGTH	ZC3H7A	426	Q8IWR0
AREIPEPRTSSHADP	SNAPC4	1181	Q5SXM2
SEPHSPGIPEIFRTA	ZNF280C	76	Q8ND82
GLDPAPSVSALTPHA	VPS72	236	Q15906
PPEPHREETVTATAT	WNK1	116	Q9H4A3
TEEPPPSLHCRFSVG	TRAPPC10	1016	P48553
RSASSEHPPGPSESK	PLEKHA1	296	Q9HB21
APPGISSIHSPSLRE	ZFYVE26	1771	Q68DK2
PGSSAPEHSPRTSGL	ULK1	536	O75385
GAPLSPVLDPARSHS	ZIC5	596	Q96T25
TPPPARSATSGHVEE	MUC12	486	Q9UKN1